<html xmlns="http://www.w3.org/1999/xhtml"> <head> <style type="text/css">
      	     		 
      	    a                          {background : #ffffff; }
      	    article                    {border-style : dotted; border-width : 2px; }
		 	
		 	div                        {background : #ffffcc;}
		 	div.abstract-title         {font-weight : bold ; font-size : 16pt;}
		 	div.ack                    {border-style : solid ; border-color : red; margin : 2em; }
		 	div.article-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.boxed-text             {margin : 5em; border-style : solid;}
		 	div.contrib-group          {margin : 1em; }
		 	div.fig                    {border-style : solid; border-width : 2px; margin : 2em; }
		 	div.funding                {font-weight : bold ; font-size : 16pt;}
		 	div.given-names            {font-style : italic;}
		 	div.intro                  {border-style : inset; margin : 5px;}
		 	div.introduction           {border-style : inset; margin : 5px;}
		 	div.journal-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.journal-title-group    {background : #ffeeee;}
		 	div.article-title          {font-weight : bold ; font-size : 18pt;}
		 	div.kwd                    {font-style : italic}
		 	div.meta-name              {font-weight : bold ; font-size : 16pt;}
		 	div.name                   {font-weight : bold;}
		 	div.alt-title              {font-style : italic; font-size : 12px;}
		 	
		 	div.sec                    {border : 2px; margin 5px; padding 2px;}
		 	div.title                  {font-family : courier; font-weight : bold;
		 	                            font-size : 16pt; margin : 5px;}
		 	
		 	div.materials_methods      {border-style : double; margin : 5px; }
		 	div.methods                {border-style : double; margin : 5px; }
		 	
		 	div.results                {border-style : solid; margin : 5px;}
		 	div.background             {border-style : dotted; margin : 5px;}
		 	
		 	div.discussion             {border-style : groove; margin : 5px;}
		 	div.conclusion             {border-style : ridge; margin : 5px;}
		 	div.conclusions             {border-style : ridge; margin : 5px;}
		 	div.supplementary-material {border-style : inset; margin : 5px;}
		 	div.abbreviations          {border-style : double; border-color : red; margin : 5px;}
		 	div.competinginterests     {border-style : double; border-color : blue; margin : 5px;}
		 	div.acknowledgements       {border-style : double; border-color : green; margin : 5px;}
		 	div.authors_contributions   {border-style : double; border-color : purple; margin : 5px;}
		 	
		 	div.publisher              {border-style : outset; margin : 5px;}
		 	div.fn-type-conflict       {background : #f88; }
		 	div.fn-type-con            {background : #ddf; }
		 	div.fn-type-other          {background : #ddd; }
		 	
		 	div.unknown                {background : #ffd;
									 	  border-style : solid;
									 	  border-width : 1px;
									 	  padding : 2 px;}
		 	  
      	    table                      {background : #ffffdd;}
		 	tr                         {background : #ddddff; padding : 1px;}
		 	
		 	span                       {background : #ffcccc;}
		 	
		 	span.citation-author       {font-family : helvetica; background : #ffeeee;}
		 	span.collab                {background : #ddffff; }
		 	span.comment               {font-family : courier; font-size : 6px; background : #ffaaff;}
		 	span.contrib               {background : #ffffff;}
		 	span.corresp               {background : #ddffdd; }
		 	span.doi                   {background : #ffffff;}
		 	span.email                 {font-family : courier; }
		 	span.etal                  {font-style : italic;}
		 	span.fpage                 {font-family : courier;}
		 	span.given-names           {background : #ffffff;}
		 	span.iso-abbrev            {background : #ffffff;}
		 	span.issn-epub             {background : #ffffff;}
		 	span.issn-ppub             {background : #ffffff;}
		 	span.journal-title         {background : #ffffff;}
		 	span.lpage                 {font-family : courier;}
		 	span.mixed-article-title   {font-style : italic ;}
		 	span.nlm-ta                {background : #ffffff;}
		 	span.pmc                   {background : #ffffff;}
		 	span.pmcid                 {background : #ffffff;}
		 	span.pmid                  {background : #ffffff;}
		 	span.publisher             {background : #ffffff;}
		 	span.publisher-id          {background : #ffffff;}
		 	span.publisher-name        {background : #ffffff;}
		 	span.source                {background : #ffffff;}
		 	span.subject               {background : #ffffff;}
		 	span.surname               {background : #ffffff;}
		 	span.volume                {font-family : courier; font-weight : bold;}
		 	span.year                  {font-family : courier ; font-style : italic;}
			</style> </head> <body> <div class="front" title="front"> <div class="journal-meta" tagx="journal-meta" title="journal-meta"><span class="nlm-ta" title="nlm-ta">Rev Esp Geriatr Gerontol</span><span class="iso-abbrev" title="iso-abbrev">Rev Esp Geriatr Gerontol</span><div class="journal-title-group" tagx="journal-title-group" title="journal-title-group"><span class="journal-title" tagx="journal-title" title="journal-title">Revista Espanola De Geriatria Y Gerontologia</span></div><span class="issn-ppub" tagx="issn" title="issn-ppub">0211-139X</span><span class="issn-epub" tagx="issn" title="issn-epub">1578-1747</span><div class="publisher" tagx="publisher" title="publisher"><span class="publisher-name" tagx="publisher-name" title="publisher-name">SEGG. Published by Elsevier EspaÃ±a, S.L.U.</span></div> </div> <div class="article-meta" tagx="article-meta" title="article-meta"><span class="pmcid" title="pmcid"> pmcid: <a href="http://www.ncbi.nlm.nih.gov/pubmed/7365050">7365050</a></span><span class="publisher-id" title="publisher-id">S0211-139X(20)30109-8</span><span class="doi" title="doi"> doi: <a href="https://dx.doi.org/10.1016/j.regg.2020.07.002">10.1016/j.regg.2020.07.002</a></span><div class="article-categories" title="article-categories">
: <span class="subject" title="subject">Article</span></div> <div class="title-group" tagx="title-group" title="title-group"> <div class="article-title" title="article-title">
Variables asociadas con mortalidad en una poblaciÃ³n de pacientes mayores de 80 aÃ±os y con algÃºn grado de dependencia funcional, hospitalizados por COVID-19 en un Servicio de GeriatrÃ­a</div><span class="trans-title-group" tagx="trans-title-group" title="trans-title-group"><span class="trans-title" tagx="trans-title" title="trans-title">Variables associated with mortality in a selected sample of patients older than 80 years and with some degree of functional dependence hospitalized for COVID-19 in a Geriatrics Service</span></span></div> <div class="contrib-group" title="contrib-group"><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">GutiÃ©rrez RodrÃ­guez</span><span class="given-names" tagx="given-names" title="given-names">JosÃ©</span></span><a href="#aff0005">a</a><a href="#aff0010">b</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Montero MuÃ±oz</span><span class="given-names" tagx="given-names" title="given-names">Javier</span></span><span class="email" tagx="email" title="email">jmonter92@gmail.com</span><a href="#aff0005">a</a><a href="#cor0005">â�Ž</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">JimÃ©nez Muela</span><span class="given-names" tagx="given-names" title="given-names">Francisco</span></span><a href="#aff0005">a</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Guirola GarcÃ­a-Prendes</span><span class="given-names" tagx="given-names" title="given-names">Cristina</span></span><a href="#aff0005">a</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">MartÃ­nez Rivera</span><span class="given-names" tagx="given-names" title="given-names">Marta</span></span><a href="#aff0005">a</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">GÃ³mez Armas</span><span class="given-names" tagx="given-names" title="given-names">Laura</span></span><a href="#aff0005">a</a></span><span class="citation_author_institution" id="aff0005">[a], </span><span class="citation_author_institution" id="aff0010">[b], </span></div> <div class="author-notes" title="author-notes"> <div class="corresp" title="corresp"><span class="label" tagx="label" title="label">â�Ž</span>Autor para correspondencia. <span class="email" tagx="email" title="email">jmonter92@gmail.com</span></div> </div><span class="pub-date-pmc-release" title="pub-date-pmc-release">pmc-release: <span>2020-7-7</span></span><span class="pub-date-epub" title="pub-date-epub">epub: <span>2020-7-7</span></span><span class="history" title="history"><span class="received" title="received">received: 2020-5-26</span><span class="accepted" title="accepted">accepted: 2020-7-13</span></span><div class="permissions"><span class="copyright" title="copyright">(C) <span class="copyright-holder" tagx="copyright-holder" title="copyright-holder">SEGG</span>, <span class="copyright-year" tagx="copyright-year" title="copyright-year">2020</span></span><span class="license" title="license"><span class="license-p" title="license-p">Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</span></span></div> <div class="abstract" title="abstract"> <div class="abstract-title" title="abstract-title">
Abstract</div> <div class="title" tagx="title" title="title">
Resumen</div> <div class="antecedentesyobjetivo" title="sec"> <div class="title" tagx="title" title="title">
Antecedentes y objetivo</div> <p>La pandemia por SARS-CoV-2 condiciona elevadas tasas de mortalidad en pacientes mayores hospitalizados. Actualmente, pocos estudios incluyen pacientes octogenarios y ninguno analiza el impacto del estado funcional sobre este resultado de salud. Nuestro objetivo es describir las caracterÃ­sticas de los pacientes mayores de 80 aÃ±os hospitalizados por <i>coronavirus disease 2019</i> (COVID-19), determinar la tasa de mortalidad e identificar factores asociados.</p> </div> <div class="materialesymÃ©todos" title="sec"> <div class="title" tagx="title" title="title">
Materiales y mÃ©todos</div> <p>Estudio observacional prospectivo realizado en mayores de 80 aÃ±os ingresados por COVID-19 en un Servicio de GeriatrÃ­a. Se recogieron variables sociodemogrÃ¡ficas, clÃ­nicas, funcionales, mentales, analÃ­ticas, radiolÃ³gicas, terapÃ©uticas y asistenciales. Se analizaron mediante anÃ¡lisis bivariante los factores asociados a mortalidad intrahospitalaria.</p> </div> <div class="resultados" title="sec"> <div class="title" tagx="title" title="title">
Resultados</div> <p>Fueron incluidos 58 casos con COVID-19 confirmado por laboratorio, edad media 88,3Â Â±Â 5,4 aÃ±os, 69% mujeres, 65,5% deterioro cognitivo moderado-severo e Ã­ndice de Barthel previo 40,6Â Â±Â 36. Los principales sÃ­ntomas fueron fiebre (60,3%), disnea (53,4%) y deterioro del estado funcional (50%). Las comorbilidades mÃ¡s frecuentes fueron enfermedad cardiovascular (75,9%), hipertensiÃ³n arterial (HTA) (74,1%) y enfermedad renal crÃ³nica (ERC) (50%). Se detectÃ³ una tasa de mortalidad del 41,4%, siendo los factores asociados: dependencia funcional severa (ORÂ =Â 3,8 [1,2-12,2]), ERC (ORÂ =Â 3,2 [1,1-9,7]), deterioro cognitivo moderado-severo (ORÂ =Â 4,9 [1 a 25,4]).</p> </div> <div class="conclusiones" title="sec"> <div class="title" tagx="title" title="title">
Conclusiones</div> <p>Se objetivan altas tasas de mortalidad en pacientes mayores hospitalizados por COVID-19, con mayor riesgo de fallecer en aquellos con dependencia funcional severa o deterioro cognitivo. Estos hallazgos refuerzan la importancia de la ValoraciÃ³n GeriÃ¡trica para elaborar estrategias que permitan adecuar la toma de decisiones diagnÃ³sticas y terapÃ©uticas y optimizar la atenciÃ³n al paciente anciano ante un nuevo brote epidÃ©mico.</p> </div> </div><span class="trans-abstract" tagx="trans-abstract" title="trans-abstract"> <div class="objective" title="sec"> <div class="title" tagx="title" title="title">
Objective</div> <p>The SARS-CoV-2 pandemic conditions high mortality rates in hospitalized elderly. Currently, a few studies include octogenarian patients and none of them analyze the impact of functional status on this health outcome. Our objective is to describe the characteristics of patients older than 80 years hospitalized for coronavirus disease 2019 (COVID-19), to determine the mortality rate and to identify associated factors.</p> </div> <div class="materialandmethods" title="sec"> <div class="title" tagx="title" title="title">
Material and methods</div> <p>Prospective observational study carried out on patients over 80 years admitted for COVID-19 in a Geriatrics Service. Sociodemographic, clinical, functional, mental, analytical, radiological, therapeutic and healthcare variables were collected. The factors associated with in-hospital lethality were analyzed by bivariate analysis.</p> </div> <div class="results" title="sec"> <div class="title" tagx="title" title="title">
Results</div> <p>58 cases with laboratory-confirmed COVID-19 were included, mean age 88.3Â Â±Â 5.4 years, 69% women, 65.5% moderate-severe cognitive impairment and previous Barthel index 40.66Â Â±Â 36. The main symptoms were fever (60,3%), dyspnea (53.4%) and deterioration of functional condition (50%). The most frequent comorbidities were cardiovascular disease (75.9%), hypertension (HT) (74.1%) and chronic kidney disease (CKD) (50%). A mortality rate of 41,4% was detected and the associated factors were: severe functional dependence (ORÂ =Â 3.8 [1.2-12.2]), moderate-severe cognitive impairment (ORÂ =Â 4.9 [1-25.4]) and CKD (ORÂ =Â 3.2 [1.1-9.7]).</p> </div> <div class="conclusion" title="sec"> <div class="title" tagx="title" title="title">
Conclusion</div> <p>High mortality rates are observed in older patients hospitalized for COVID-19, with a higher risk of dying in those with severe functional dependence or cognitive impairment. These findings reinforce the value of Geriatric Assessment to develop strategies to adapt diagnostic and therapeutic decision-making and to optimize care for elderly patients in the event of a new epidemic outbreak.</p> </div></span><div class="kwd-group"> <div class="title" tagx="title" title="title">
Palabras clave</div> <div class="kwd" title="kwd">
SARS-CoV-2</div> <div class="kwd" title="kwd">
COVID-19</div> <div class="kwd" title="kwd">
Personas mayores</div> <div class="kwd" title="kwd">
Dependencia funcional</div> <div class="kwd" title="kwd">
Mortalidad</div> </div> <div class="kwd-group"> <div class="title" tagx="title" title="title">
Keywords</div> <div class="kwd" title="kwd">
SARS-CoV-2</div> <div class="kwd" title="kwd">
COVID-19</div> <div class="kwd" title="kwd">
Older patients</div> <div class="kwd" title="kwd">
Functional impairment</div> <div class="kwd" title="kwd">
Mortality</div> </div> </div> </div> <div class="body" title="body"> <div class="introducciÃ³n" title="sec"> <div class="title" tagx="title" title="title">
IntroducciÃ³n</div> <p id="par0005">El dÃ­a 30 de enero de 2020 la OrganizaciÃ³n Mundial de la Salud (OMS) declarÃ³ el brote de nuevo coronavirus 2019 (nCoV) en China como una Emergencia de Salud PÃºblica de Importancia Internacional<a href="#bib0205"><sup>1</sup></a>. Posteriormente, el 11 de marzo proclamÃ³ la pandemia mundial por el virus de la familia Coronaviridae nombrado oficialmente como <i>severe acute respiratory syndrome coronavirus 2</i> (SARS-CoV-2)<a href="#bib0210"><sup>2</sup></a>, virus que puede infectar al ser humano provocando un cuadro clÃ­nico denominado <i>coronavirus disease 2019</i> (COVID-19).</p> <p id="par0010">Estudios realizados en poblaciÃ³n china han reportado que los pacientes hospitalizados por COVID-19 presentan elevado riesgo de sufrir neumonÃ­a grave con unas tasas de mortalidad dispares que varÃ­an entre el 4,3% y el 45%<a href="#bib0215">3</a>, <a href="#bib0220">4</a>, <a href="#bib0225">5</a>, <a href="#bib0230">6</a>, <a href="#bib0235">7</a>, <a href="#bib0240">8</a>, <a href="#bib0245">9</a>, <a href="#bib0250">10</a>, <a href="#bib0255">11</a>; cifra que se eleva al 34.5% en poblaciÃ³n mayor de 65 aÃ±os<a href="#bib0260"><sup>12</sup></a>, al 90% o 100% en poblaciÃ³n mayor de 70 y 80 aÃ±os, respectivamente<a href="#bib0245"><sup>9</sup></a>, y al 53,7% en pacientes neoyorquinos mayores de 80 aÃ±os<a href="#bib0265"><sup>13</sup></a>. En nuestro paÃ­s, una serie realizada sobre 6.424 pacientes hospitalizados por COVID-19 con rango de edad entre 18 y 102 aÃ±os (23,5% mayores de 80 aÃ±os) describe una mortalidad del 21,1%<a href="#bib0270"><sup>14</sup></a>.</p> <p id="par0015">En estos estudios se objetiva que los sÃ­ntomas mÃ¡s frecuentes que presentan los pacientes mayores afectados por COVID-19 son: fiebre, disnea, tos, mialgia y astenia<a href="#bib0260">12</a>, <a href="#bib0275">15</a>, <a href="#bib0280">16</a>, <a href="#bib0285">17</a>, <a href="#bib0290">18</a>, <a href="#bib0295">19</a>. Sin embargo, en su diseÃ±o no se tiene en cuenta la presentaciÃ³n atÃ­pica de la enfermedad en el paciente anciano, excepto en el estudio francÃ©s de Godaert et al.<a href="#bib0275"><sup>15</sup></a> que incluye delirium y caÃ­das, y el original italiano de Bianchetti et al.<a href="#bib0300"><sup>20</sup></a> que recoge sÃ­ntomas atÃ­picos como el deterioro del estado funcional y la existencia de <i>delirium</i> hiper- e hipoactivo.</p> <p id="par0020">Algunos autores han analizado los factores asociados con la gravedad de la enfermedad y al riesgo de muerte por COVID-19, entre los que se han descrito: sexo masculino, existencia de hipertensiÃ³n arterial, intensidad de la disnea, registro de leucocitosis o linfopenia, elevaciÃ³n de d-DÃ­mero o complicaciÃ³n con insuficiencia cardiaca<a href="#bib0220">4</a>, <a href="#bib0225">5</a>, <a href="#bib0230">6</a>, <a href="#bib0235">7</a>, <a href="#bib0240">8</a>, <a href="#bib0245">9</a>, <a href="#bib0250">10</a>, <a href="#bib0255">11</a>, <a href="#bib0260">12</a>, <a href="#bib0290">18</a>, <a href="#bib0295">19</a>. Pero en ninguno de ellos se contempla la posibilidad de evaluar la influencia de aspectos como la capacidad funcional o el deterioro cognitivo, variables con un elevado impacto en los resultados de salud del paciente anciano.</p> <p id="par0025">En definitiva, actualmente disponemos de diversas series de casos que describen las caracterÃ­sticas epidemiolÃ³gicas y clÃ­nicas y las tasas de mortalidad del COVID-19 en China. Sin embargo, son menos numerosas las realizadas en otros paÃ­ses o las que especÃ­ficamente se dirigen a pacientes mayores y evalÃºan la presentaciÃ³n atÃ­pica de la enfermedad o analizan la influencia de la situaciÃ³n funcional y el estado cognitivo en la mortalidad de los pacientes.</p> <p id="par0030">El 31 de enero fue detectado el primer caso de infecciÃ³n por SARS-CoV-2 en EspaÃ±a. Posteriormente la enfermedad se extendiÃ³ por todo el estado confirmando altas tasas de infectividad, hospitalizaciÃ³n, ingresos en UCI y mortalidad, que condicionaron un elevado impacto asistencial sobre nuestro sistema de salud<a href="#bib0305"><sup>21</sup></a>. De esta forma, en nuestro paÃ­s, el 20 de marzo se habÃ­an contabilizado 19.980 casos y 1.002 fallecidos y en nuestra comunidad autÃ³noma 344 casos y dos fallecidos.</p> <p id="par0035">Ese mismo dÃ­a, tras un gran esfuerzo organizativo se abren las plantas para pacientes con COVID-19 en nuestro centro hospitalario: un total de 38 camas destinadas a pacientes mayores de 80 aÃ±os con infecciÃ³n por coronavirus, que precisan hospitalizaciÃ³n por presentar insuficiencia respiratoria aguda o descompensaciÃ³n de patologÃ­a de base y que, en caso de empeoramiento clÃ­nico, no serÃ­an subsidiarios de beneficio de ingreso en UCI por sufrir algÃºn grado de dependencia funcional y/o deterioro cognitivo<a href="#bib0310"><sup>22</sup></a>.</p> <p id="par0040">En este Ã¡mbito asistencial, los objetivos de este trabajo han sido: a) estudiar las caracterÃ­sticas epidemiolÃ³gicas, clÃ­nicas, analÃ­ticas y radiolÃ³gicas de pacientes mayores de 80 aÃ±os con algÃºn grado de dependencia funcional y/o deterioro cognitivo ingresados con COVID-19 confirmado por diagnÃ³stico de laboratorio, b) determinar la tasa de mortalidad, c) analizar las variables clÃ­nicas, terapÃ©uticas, funcionales y mentales que se asocian a mayor riesgo de mortalidad.</p> </div> <div class="materialymÃ©todos" title="sec"> <div class="title" tagx="title" title="title">
Material y mÃ©todos</div> <p id="par0045">Estudio epidemiolÃ³gico observacional y prospectivo en el que se incluyeron todos los sujetos mayores de 80 aÃ±os hospitalizados en nuestra Unidad de Agudos de GeriatrÃ­a, con diagnÃ³stico de COVID-19 confirmado por laboratorio, entre el 20 de marzo y el 19 de abril de 2020.</p> <p id="par0050">Nuestro Servicio de GeriatrÃ­a estÃ¡ incluido en el complejo hospitalario de referencia del Ã�rea Sanitaria IV de nuestra Comunidad AutÃ³noma. Los pacientes mayores de 80 aÃ±os que acudieron al Servicio de Urgencias del complejo con diagnÃ³stico de COVID-19 y eran independientes para actividades de la vida diaria y no presentaban deterioro cognitivo, ingresaban en el Servicio de Medicina Interna. Aquellos que presentaban algÃºn grado de dependencia funcional y/o deterioro cognitivo, ingresaban en el Servicio de GeriatrÃ­a.</p> <p id="par0055">De los 108 pacientes ingresados 50 fueron excluidos del estudio: 18 por presentar alta sospecha epidemiolÃ³gica, clÃ­nica, analÃ­tica y radiolÃ³gica de COVID-19, sin ser confirmada por laboratorio en varias muestras solicitadas de forma repetida durante todo el proceso desde su ingreso hasta el dÃ­a del alta, y 32 pacientes por permanecer ingresados en el momento del anÃ¡lisis.</p> <p id="par0060">La confirmaciÃ³n de laboratorio de COVID-19 fue definida como resultado positivo en la reacciÃ³n en cadena de la polimerasa (RT-PCR) en frotis nasofarÃ­ngeo u orofarÃ­ngeo realizada por el Servicio de MicrobiologÃ­a de nuestro complejo hospitalario. Tal como en otros estudios se ha objetivado, esta tÃ©cnica microbiolÃ³gica presenta ciertas limitaciones (momento de recogida de la muestra con respecto al inicio de los sÃ­ntomas, muestra insuficiente o deterioro de la misma) que disminuyen la capacidad de diagnosticar la totalidad de los casos.</p> <p id="par0065">Para equiparar la terminologÃ­a de este trabajo a las referencias bibliogrÃ¡ficas existentes, se ha utilizado el tÃ©rmino Â«tasa de mortalidadÂ», aunque segÃºn el Â«Glosario de TÃ©rminos EpidemiolÃ³gicos del Grupo de AnÃ¡lisis CientÃ­fico de Coronavirus del ISCIIIÂ» se podrÃ­a haber utilizado el tÃ©rmino letalidad o Â«proporciÃ³n de casos de una enfermedad que resultan mortales con respecto al total de casos en un periodo de tiempoÂ»<a href="#bib0315"><sup>23</sup></a>.</p> <p id="par0070">Los datos fueron recogidos de la historia clÃ­nica electrÃ³nica utilizando un protocolo estÃ¡ndar predefinido que incluÃ­a las siguientes variables: a) sociodemogrÃ¡ficas: edad, sexo y domicilio (particular o residencia); b) clÃ­nicas: enfermedad cardiovascular (cardiopatÃ­a estructural, sÃ­ndrome coronario agudo, insuficiencia cardÃ­aca, arteriopatÃ­a perifÃ©rica, arritmias), hipertensiÃ³n arterial (HTA), diabetes mellitus (DM), dislipemia (DL), cÃ¡ncer, enfermedad pulmonar obstructiva crÃ³nica (EPOC) y enfermedad renal crÃ³nica (ERC); c) situaciÃ³n funcional basal o capacidad funcional previa a la enfermedad aguda: evaluada mediante el Ã­ndice de Barthel y estratificada como independiente (100-95), dependencia leve (60-90), moderada (45-55), grave (20-40) o total (0-15); d) deterioro cognitivo: evaluado mediante la <i>Global Deterioration Scale de Reisberg</i> (GDS) y estratificado como 1 (sin dÃ©ficit cognitivo), 2-3 (deterioro cognitivo leve), 4-5 (moderado) y 6-7 (grave); e) sintomatologÃ­a al ingreso: fiebre, tos, disnea, mialgia, deterioro del estado funcional (definido como el deterioro en alguna de las actividades bÃ¡sicas de la vida diaria), <i>delirium</i>, cefalea, dolor de faringe, nÃ¡useas/vÃ³mitos, diarrea, anorexia y caÃ­das; f) dÃ­as desde el inicio de los sÃ­ntomas hasta la hospitalizaciÃ³n; g) analÃ­tica al ingreso: leucocitos, linfocitos, plaquetas, hemoglobina, tiempo de tromboplastina parcial activada (TTPa), tiempo de protrombina, d-DÃ­mero, glucosa, sodio, potasio, urea, creatinina, ferritina, proteÃ­na C reactiva (PCR), lactato deshidrogenasa (LDH), creatina cinasa (CK), troponina T (TropT), procalcitonina, albÃºmina, alanino aminotransferasa (ALT), aspartato aminotransferasa (AST), gamma glutamil transferasa (GGT), bilirrubina, fosfatasa alcalina y NTproBNP; h) radiologÃ­a al ingreso: infiltrados alveolares unilaterales, bilaterales e intersticiales o patrÃ³n en vidrio deslustrado; i) microbiolÃ³gicas: reacciÃ³n en cadena de la polimerasa (RT-PCR) para SARS-CoV-2 y nÃºmero de copias; j) terapÃ©uticas: prescripciÃ³n durante el ingreso de hidroxicloroquina, azitromicina, ceftriaxona, otros antibiÃ³ticos, esteroides, antivirales o inmunoglobulinas; k) asistenciales: dÃ­as de estancia, alta a domicilio o <i>exitus letalis</i>.</p> <p id="par0075">El estudio fue aprobado por la direcciÃ³n del centro, recibiÃ³ el visto bueno por parte de del comitÃ© de Ã©tica y se recogiÃ³ el consentimiento informado del propio paciente o, en su defecto, del familiar responsable o cuidador principal.</p> <p id="par0080">No se ha contado con ningÃºn promotor privado, ni de la industria farmacÃ©utica ni sociedad cientÃ­fica ni ninguna otra fuente de financiaciÃ³n. Se ha realizado una recopilaciÃ³n de datos con fines observacionales, sin interferir en las actividades diarias del centro en tÃ©rminos de gestiÃ³n clÃ­nica y terapÃ©utica de los pacientes.</p> <p id="par0085">No se realizÃ³ un cÃ¡lculo del tamaÃ±o muestral <i>aÂ priori</i> y los datos fueron recogidos por un mÃ©dico interno residente segÃºn un protocolo de estudio predefinido.</p> <p id="par0090">Desde el punto de vista estadÃ­stico, se realizÃ³ una descripciÃ³n de la poblaciÃ³n de estudio utilizando frecuencias para las variables cualitativas y media y desviaciÃ³n estÃ¡ndar para las cuantitativas. AsÃ­ mismo, se calculÃ³ la mortalidad por SARS-CoV-2 durante el ingreso.</p> <p id="par0095">Para analizar la posible asociaciÃ³n estadÃ­stica entre las variables independientes y la variable dependiente o muerte se realizÃ³ un anÃ¡lisis bivariante utilizÃ¡ndose los <i>test</i> chi-cuadrado (para las variables cualitativas) y la t de Student (para las variables cuantitativas). La fuerza de asociaciÃ³n de las variables cualitativas se midiÃ³ mediante la <i>Odds Ratio</i> y sus lÃ­mites de confianza (pÂ <div class="â_UNKNOWN"> </div></p></div> <div class="resultados" title="sec"> <div class="title" tagx="title" title="title">
Resultados</div> <p id="par0100">Un total de 58 pacientes fueron sistemÃ¡ticamente valorados e incluidos en el estudio. La edad media fue de 88,3Â Â±Â 5,4 aÃ±os y el 69% eran mujeres. El 70,7% estaban institucionalizados, presentaban una puntuaciÃ³n media en el Ã­ndice de Barthel previo de 40,6Â Â±Â 36,0 y en el 65,5% de los sujetos se detectÃ³ un deterioro cognitivo moderado o grave (<a href="#tbl0005">tabla 1</a> ). <div class="table-wrap_UNKNOWN" position="float" id="tbl0005"><span class="label" tagx="label" title="label">Tabla 1</span> </div></p><p>CaracterÃ­sticas demogrÃ¡ficas, clÃ­nicas, funcionales y mentales de la poblaciÃ³n de estudio. Comparativa con otras series</p>  <div tag="alt-text">
Tabla 1</div> <table frame="hsides" rules="groups"> <thead> <tr> <th /> <th align="left">HMN</th> <th align="left">Chen et al.<a href="#bib0260"><sup>12</sup></a><sup>,</sup><a href="#tblfn0005">a</a></th> <th align="left">Godaert et al.<a href="#bib0275"><sup>15</sup></a><sup>,</sup><a href="#tblfn0005">a</a></th> <th align="left">Lian et al.<a href="#bib0280"><sup>16</sup></a><sup>,</sup><a href="#tblfn0005">a</a></th> <th align="left">Liu et al.<a href="#bib0285"><sup>17</sup></a><sup>,</sup><a href="#tblfn0005">a</a></th> <th align="left">Wang et al.<a href="#bib0290"><sup>18</sup></a><sup>,</sup><a href="#tblfn0005">a</a></th> </tr> </thead> <tbody> <tr> <td align="left">PaÃ­s</td> <td align="left">EspaÃ±a</td> <td align="left">China</td> <td align="left">Francia</td> <td align="left">China</td> <td align="left">China</td> <td align="left">China</td> </tr> <tr> <td align="left">n</td> <td align="left">58</td> <td align="left">55</td> <td align="left">17</td> <td align="left">136</td> <td align="left">18</td> <td align="left">339</td> </tr> <tr> <td align="left">Edad; aÃ±os (DE)<br /><br />Mujer; n (%)<br /><br />InstitucionalizaciÃ³n; n (%)</td> <td align="left">88,3 (5,4)<br /><br />40 (69)<br /><br />41 (70,7)</td> <td align="left">74 (65-91)<br /><br />21 (38,2)</td> <td align="left">86,5 (68,6-97,1)<br /><br />9 (52,9)</td> <td align="left">68,3 (7,3)<br /><br />78 (57,3)</td> <td align="left">68 (65,3-69,8)<br /><br />6 (33,3)</td> <td align="left">69 (65-76)<br /><br />173 (51)</td> </tr> <tr> <td align="left">Dep. funcional; nÂ (%)<br /><br /><i>independiente (IB 95-100)</i><br /><br /><i>leve (IB 60-90)</i><br /><br /><i>moderada (IB 45-55)</i><br /><br /><i>grave-total (IB 0-40)</i><br /><br />Deterioro cognitivo; nÂ (%)<br /><br /><i>no deterioro cognitivo (GDS 1)</i><br /><br /><i>leve (GDS 2-3)</i><br /><br /><i>moderado-grave (GDS &amp;gt; 3</i>)</td> <td align="left"><br /><br />2 (3,4)<br /><br />18 (31,0)<br /><br />6 (10,3)<br /><br />30 (51,7)<br /><br /><br /><br />13 (22,8)<br /><br />6 (10,3)<br /><br />38 (65,5)</td> <td /> <td /> <td /> <td /> <td /> </tr> <tr> <td align="left">Comorbilidades; nÂ (%)<br /><br /><i>Enf. cardiovascular</i><br /><br /><i>Enf. digestiva</i><br /><br /><i>HTA</i><br /><br /><i>DM</i><br /><br /><i>DL</i><br /><br /><i>CÃ¡ncer</i><br /><br /><i>EPOC/asma</i><br /><br /><i>ERC</i></td> <td align="left"><br /><br />44 (75,9)<br /><br />14 (24,1)<br /><br />43 (74,1)<br /><br />17 (29,3)<br /><br />27 (46,6)<br /><br />4 (6,9)<br /><br />7 (12,1)<br /><br />29 (50)</td> <td align="left"><br /><br />11 (20)<br /><br /><br /><br />21 (38,2)<br /><br />12 (21,8)<br /><br /><br /><br />5 (9,1)<br /><br />7 (12,7)<br /><br />3 (5,5)</td> <td /> <td align="left"><br /><br />6 (4,4)<br /><br /><br /><br />53 (39)<br /><br />24 (17,6)<br /><br /><br /><br />3 (2,2)<br /><br />3 (2,2)<br /><br />2 (1,5)</td> <td align="left"><br /><br /><br /><br />5 (27,8)<br /><br />3 (16,7)<br /><br /><br /><br />0 (0)</td> <td align="left"><br /><br />53 (15,7)<br /><br /><br /><br />138 (40,8)<br /><br />54 (16)<br /><br /><br /><br />15 (4,4)<br /><br />21 (6,2)<br /><br />13 (3,8)</td> </tr> <tr> <td align="left">SÃ­ntomas; n (%)<br /><br /><i>Fiebre</i><br /><br /><i>Tos</i><br /><br /><i>Disnea</i><br /><br /><i>Mialgia</i><br /><br /><i>Astenia</i><br /><br /><i>Cefalea</i><br /><br /><i>Dolor de faringe</i><br /><br /><i>Nauseas/vÃ³mitos</i><br /><br /><i>Diarrea</i><br /><br /><i>Anorexia</i><br /><br /><i>Deterioro del estado funcional</i><br /><br /><i>Delirium</i><br /><br /><i>CaÃ­das</i></td> <td align="left"><br /><br />35 (60,3)<br /><br />24 (41,4)<br /><br />31 (53,4)<br /><br />3 (5,2)<br /><br /><br /><br />1 (1,7)<br /><br />0 (0)<br /><br />4 (6,9)<br /><br />8 (13,8)<br /><br />9 (15,5)<br /><br />29 (50)<br /><br />11 (19)<br /><br />3 (5,2)</td> <td align="left"><br /><br />52 (94,5)<br /><br />38 (69,1)<br /><br />32 (58,2)<br /><br />11 (20)<br /><br />5 (9,1)<br /><br />3 (5,5)<br /><br /><br /><br />2 (3,6)<br /><br />3 (5,5)<br /><br />5 (9,1)</td> <td align="left"><br /><br />13 (76,5)<br /><br />12 (70,6)<br /><br />11 (64,7)<br /><br /><br /><br />10 (58,8)<br /><br /><br /><br />9 (52,9)<br /><br />4 (23,5)</td> <td align="left"><br /><br />115 (84,6)<br /><br />85 (62,5)<br /><br />17 (12,5)<br /><br />20 (14,7)<br /><br />24 (17,7)<br /><br />8 (5,9)<br /><br />17 (12,5)<br /><br /><br /><br /></td> <td align="left"><br /><br />14 (77,8)<br /><br /><br /><br />2 (11,1)<br /><br /><br /><br />2 (11,1)<br /><br /><br /><br />3 (16,7)</td> <td align="left"><br /><br />311 (92)<br /><br />179 (53)<br /><br />138 (40,8)<br /><br />16 (4,7)<br /><br />135 (39,9)<br /><br />12 (3,5)<br /><br />13 (3,9)<br /><br />13 (3,8)<br /><br />43 (12,7)<br /><br />94 (27,8)<br /><br /></td> </tr> <tr> <td align="left">Leucocitos; Ã—10<sup>9</sup>/L (DE)<br /><br /><i>&amp;lt; 4</i> Ã—<i>10</i><sup><i>9</i></sup><i>/L; nÂ (%)</i><br /><br />Linfocitos; Ã—10<sup>9</sup>/L (DE)<br /><br /><i>&amp;lt; 1x10</i><sup><i>9</i></sup><i>/L; nÂ (%)</i><br /><br />Plaquetas; Ã—10<sup>9</sup>/L (DE)<br /><br /><i>&amp;lt; 100</i> Ã—<i>10</i><sup><i>9</i></sup><i>/L; nÂ (%)</i><br /><br />Hemoglobina; g/L (DE)<br /><br /><i>&amp;lt;12 g/L; nÂ (%)</i></td> <td align="left">7,6 (4,3)<br /><br />8 (13,8)<br /><br />1 (0,7)<br /><br />35 (60,3)<br /><br />197 (98,4)<br /><br />4 (6,9)<br /><br />12,6 (1,7)<br /><br />21 (36,2)</td> <td align="left">6,1(2-25,7)<br /><br />20 (36,4)<br /><br />0,89 (0-6)<br /><br />45 (81,8)<br /><br />162 (22-414)<br /><br />9 (16,4)</td> <td align="left"><br /><br /><br /><br />13 (76,5)<br /><br /><br /><br />7 (41,2)</td> <td align="left">4,8 (3,9-6,4)<br /><br />38 (27,9)<br /><br />1,1 (0,7-1,4)<br /><br />42 (30,9)<br /><br />169,5 (132-207,5)<br /><br />7 (5,2)<br /><br />12,9 (12-14,1)</td> <td align="left">5,4 (4,3-6,1)<br /><br />3 (16,7)<br /><br /><br /><br />207 (159-287)<br /><br /><br /><br />10,7 (9,2-12)</td> <td align="left">5,7 (4,4-8,3)<br /><br /><br /><br />0,9 (0,6-1,3)<br /><br /><br /><br />205 (151-259)<br /><br /><br /><br />12,1 (10,9-13)</td> </tr> <tr> <td align="left">TTPa; segundos (DE)<br /><br />TP; segundos (DE)<br /><br />D-DÃ­mero; microg/L (DE)<br /><br /></td> <td align="left">36,6 (37,4)<br /><br />18,5 (31,2)<br /><br />8.095<br /><br />(22.794,5)</td> <td align="left"><br /><br /><br /><br />1.354<br /><br />(108-18.825)</td> <td /> <td /> <td /> <td align="left">28,5 (26,2-31,3)<br /><br />12,1 (11,6-12,7)<br /><br />1.200 (620-3.250)</td> </tr> <tr> <td align="left">Glucosa; mg/dL (DE)<br /><br />Sodio; mmol/L (DE)<br /><br />Potasio; mmol/L (DE)<br /><br />Urea; mg/dL (DE)<br /><br />Creatinina; mg/dL (DE)<br /><br />Ferritina; ng/mL (DE)<br /><br />PCR; mg/dL (DE)<br /><br />LDH; U/L (DE)<br /><br />CK; U/L (DE)<br /><br />TropT; ng/L (DE)<br /><br />Procalcitonina; ng/mL (DE)<br /><br />AlbÃºmina; g/L (DE)<br /><br />ALT; U/L (DE)<br /><br />AST; U/L (DE)<br /><br />GGT; U/L (DE)<br /><br />Bilirrubina; mg/dL (DE)<br /><br />Fosfatasa alcalina; U/L (DE)<br /><br />NTproBNP; pg/mL (DE)</td> <td align="left">159,1 (92,2)<br /><br />141,4 (7,4)<br /><br />4,2 (0,8)<br /><br />81,4 (50,2)<br /><br />1,42 (0,79)<br /><br />654 (628,4)<br /><br />7,5 (8)<br /><br />373,8 (196,8)<br /><br />522,6 (2.191,6)<br /><br />186,1 (591)<br /><br />1,37 (3)<br /><br />33,3 (3,7)<br /><br />26,5 (30,1)<br /><br />79 (145,1)<br /><br />60,5 (47,4)<br /><br />1,1 (0,4)<br /><br />99,7 (60,9)<br /><br />4.967,3 (8.897)</td> <td align="left"><br /><br /><br /><br />1,18 (0,42-8,89)<br /><br /><br /><br />8,5 (0,2-28,4)<br /><br />395 (153-775)<br /><br />141,2 (13-972)<br /><br /><br /><br />0,48 (0-8)<br /><br />33,3 (25-43)<br /><br />41,3 (8-279)<br /><br />63,1 (18-209)<br /><br /><br /><br /></td> <td /> <td align="left"><br /><br />137 (135-139,1)<br /><br />3,9 (3,6-4,1)<br /><br />26,4 (21,6-35.4)<br /><br />0,78 (0,66-0,9)<br /><br /><br /><br />1,9 (0,6-4,5)<br /><br />244 (206-311)<br /><br />74,5 (52,3-123)<br /><br /><br /><br />39,2 (36-42)<br /><br />21 (16-29)<br /><br />28 (22-36)<br /><br /><br /><br />0,6 (0,4-0,8)</td> <td align="left"><br /><br /><br /><br />1,2 (0,9-1,7)<br /><br /><br /><br />2,3 (1,3-3,5)<br /><br /><br /><br />0,04 (0,02-0,09)<br /><br />33 (29-38)<br /><br /><br /><br /></td> <td align="left"><br /><br /><br /><br />33 (24-48,1)<br /><br />0,69 (0,56-0,86)<br /><br /><br /><br />4,9 (1,9-9,3)<br /><br />301 (224-429)<br /><br />63 (40-104)<br /><br />0,01 (0,006-0,02)<br /><br />0,08 (0,04-0,17)<br /><br /><br /><br />27 (17-44)<br /><br />32 (23-46)</td> </tr> <tr> <td align="left">RadiologÃ­a; n (%)<br /><br /><i>Sin alteraciones</i><br /><br /><i>NeumonÃ­a unilateral</i><br /><br /><i>NeumonÃ­a bilateral</i><br /><br /><i>Moteado mÃºltiple o patrÃ³n en vidrio deslustrado</i></td> <td align="left"><br /><br />19 (32.8)<br /><br />7 (12,1)<br /><br />22 (37,9)<br /><br /><br /><br />20 (34,5)</td> <td align="left"><br /><br /><br /><br />54 (98,2)</td> <td /> <td align="left"><br /><br />5 (3,7)<br /><br />15 (11)<br /><br />57 (41,9)<br /><br /><br /><br />59 (43,4)</td> <td align="left"><br /><br /><br /><br />2 (11,1)<br /><br />16 (88,9)</td> <td /> </tr> <tr> <td align="left">RT-PCR; carga viral, copias/1.000 cÃ©lulas (DE)</td> <td align="left">3,64Â Ã—10<sup>7</sup> (1,37Â Ã—10<sup>8</sup>)</td> <td /> <td /> <td /> <td /> <td /> </tr> </tbody> </table> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""> <p>ALT: alanina aminotransfesasa; AST: aspartato aminotransferasa; CK: creatina cinasa; DM: diabetes mellitus; EPOC: enfermedad pulmonar obstructiva crÃ³nica; ERC: enfermedad renal crÃ³nica; GDS: <i>Global Deterioration Scale</i>; GGT: gamma glutamil transferasa; HTA: hipertensiÃ³n arterial; IB: Ã�ndice de Barthel; IL-6: interleucina 6; LDH: lactato-deshidrogenasa; PCR: proteÃ­na C reactiva; TP: tasa de protrombina; TropT: troponina T; TTPa: tiempo de tromboplastina parcial activada.</p> </div> </div> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""><span class="label" tagx="label" title="label">a</span><p id="npar0005">Variables cuantitativas expresadas con medianas (rango intercuartÃ­lico).</p> </div> </div>  <p /> <p id="par0105">Dentro de los antecedentes personales, los mÃ¡s prevalentes fueron enfermedad cardiovascular, HTA, demencia y ERC.</p> <p id="par0110">Los pacientes comenzaron con los sÃ­ntomas 2,6Â Â±Â 3,7 dÃ­as antes de la hospitalizaciÃ³n, siendo los mÃ¡s frecuentes fiebre, disnea y deterioro del estado funcional. El 96,6% ingresÃ³ desde el Servicio de Urgencias y un 3,4% directamente desde su centro residencial.</p> <p id="par0115">En el momento del ingreso, un elevado porcentaje de pacientes presentaban linfopenia (60,3%), elevaciÃ³n de d-DÃ­mero, CK, Trop-T, ferritina y LDH y en la mayorÃ­a de los casos se describieron imÃ¡genes radiolÃ³gicas tÃ­picas de COVID-19 (<a href="#tbl0005">tabla 1</a>).</p> <p id="par0120">Los pacientes mostraban una carga viral media de mÃ¡s de 36 millones de copias de SARS-CoV-2.</p> <p id="par0125">El tratamiento pautado con mayor frecuencia fueron los antibiÃ³ticos, destacando la utilizaciÃ³n de azitromicina y ceftriaxona (<a href="#tbl0010">tabla 2</a> ). NingÃºn paciente fue tratado con antivirales o inmunoglobulinas. <div class="table-wrap_UNKNOWN" position="float" id="tbl0010"><span class="label" tagx="label" title="label">Tabla 2</span> </div></p><p>DescripciÃ³n de las variables terapÃ©uticas y asistenciales</p>  <div tag="alt-text">
Tabla 2</div> <table frame="hsides" rules="groups"> <thead> <tr> <th /> <th align="left">HMN</th> <th align="left">Chen et al.<a href="#bib0260"><sup>12</sup></a><sup>,</sup><a href="#tblfn0010">a</a></th> <th align="left">Godaert et al.<a href="#bib0275"><sup>15</sup></a></th> <th align="left">Lian et al.<a href="#bib0280"><sup>16</sup></a></th> <th align="left">Liu et al.<a href="#bib0285"><sup>17</sup></a></th> <th align="left">Wang et al.<a href="#bib0290"><sup>18</sup></a></th> </tr> </thead> <tbody> <tr> <td align="left">PaÃ­s</td> <td align="left">EspaÃ±a</td> <td align="left">China</td> <td align="left">Francia</td> <td align="left">China</td> <td align="left">China</td> <td align="left">China</td> </tr> <tr> <td align="left">n</td> <td align="left">58</td> <td align="left">55</td> <td align="left">17</td> <td align="left">136</td> <td align="left">18</td> <td align="left">339</td> </tr> <tr> <td align="left">Tratamiento; n (%)<br /><br />Hidroxicloroquina<br /><br />Azitromicina<br /><br />Ceftriaxona<br /><br />Otros antibiÃ³ticos<br /><br />Glucocorticoides<br /><br />Antivirales<br /><br />Inmunoglobulinas</td> <td align="left"><br /><br />7 (12,1)<br /><br />42 (72,4)<br /><br />36 (62,1)<br /><br />19 (32,8)<br /><br />10 (17,2)</td> <td align="left"><br /><br /><br /><br />34 (61,8)<br /><br />10 (18,2)<br /><br />5 (9,1)</td> <td /> <td align="left"><br /><br /><br /><br />39 (28,7)<br /><br />117 (86)</td> <td align="left"><br /><br /><br /><br />12 (66,6)<br /><br /><br /><br />16 (83,3)<br /><br />4 (22,2)</td> <td /> </tr> <tr> <td align="left">Estancia media; dÃ­as (DE)</td> <td align="left">13,3 (8,2)</td> <td align="left">12 (1-45)</td> <td /> <td /> <td /> <td /> </tr> <tr> <td align="left">Alta a su domicilio/residencia<br /><br />Mortalidad</td> <td align="left">34 (58,6)<br /><br />24 (41,4)</td> <td align="left"><br /><br />19 (34,5)</td> <td /> <td /> <td align="left">17 (94,4)<br /><br />1 (5,6)</td> <td /> </tr> </tbody> </table> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""><span class="label" tagx="label" title="label">a</span><p id="npar0010">Variables cuantitativas expresadas con medianas (rango intercuartÃ­lico).</p> </div> </div>  <p /> <p id="par0130">Se detectÃ³ una tasa de mortalidad del 41,4%. Al analizar los posibles factores asociados al riesgo de muerte, de todas las variables incluidas en el estudio Ãºnicamente mostraron asociaciÃ³n estadÃ­stica la puntuaciÃ³n en el Ã­ndice de Barthel, la existencia de deterioro cognitivo y la presencia en los antecedentes personales de ERC (<a href="#tbl0015">Tabla 3</a>, <a href="#tbl0020">Tabla 4</a> ). De forma que a mayor grado de dependencia funcional los pacientes presentaban mayor riesgo de muerte. AsÃ­ mismo, se objetivÃ³ que la presencia de deterioro cognitivo moderado-severo podrÃ­a ser un factor de mal pronÃ³stico. <div class="table-wrap_UNKNOWN" position="float" id="tbl0015"><span class="label" tagx="label" title="label">Tabla 3</span> </div></p><p>Variables clÃ­nicas asociadas a mortalidad por COVID-19</p>  <div tag="alt-text">
Tabla 3</div> <table frame="hsides" rules="groups"> <thead> <tr> <th /> <th align="left">No <i>exitus</i><br /><br />(n=34)</th> <th align="left"><i>Exitus</i><br /><br />(n=24)</th> <th align="left">Diferencia de medias / OR (ICÂ 95%)</th> <th align="left">p</th> </tr> </thead> <tbody> <tr> <td align="left">Edad; aÃ±os (DE)<br /><br />Mujer; n (%)<br /><br />InstitucionalizaciÃ³n; n (%)</td> <td align="left">87,4 (5,1)<br /><br />24 (70,6)<br /><br />23 (67,6)</td> <td align="left">89,7 (5,5)<br /><br />69 (66,7)<br /><br />18 (75)</td> <td align="left">2,3 (-0,5 a 5,1)<br /><br />OR 0,8 (0,3 a 2,6)<br /><br />OR 1,4 (0,4 a 4,6)</td> <td align="left">0,104<br /><br />0,751<br /><br />0,545</td> </tr> <tr> <td align="left">Comorbilidades; n (%)<br /><br />Enf. cardiovascular<br /><br />Enf. digestiva<br /><br />HTA<br /><br />DM<br /><br />DL<br /><br />CÃ¡ncer<br /><br />EPOC/asma<br /><br />ERC</td> <td align="left"><br /><br />26 (76,5)<br /><br />11 (32,4)<br /><br />23 (67,6)<br /><br />11 (32,4)<br /><br />15 (44,1)<br /><br />2 (5,9)<br /><br />4 (11,8)<br /><br />13 (38,2)</td> <td align="left"><br /><br />18 (75)<br /><br />3 (12,5)<br /><br />20 (83,3)<br /><br />6 (25)<br /><br />12 (50)<br /><br />2 (8,3)<br /><br />3 (12,5)<br /><br />16 (66,7)</td> <td align="left"><br /><br />OR 0,9 (0,3 a 3,1)<br /><br />OR 0,3 (0,1 a 1,2)<br /><br />OR 2,4 (0,7 a 8,7)<br /><br />OR 0,7 (0,2 a 2,2)<br /><br />OR 1,3 (0,4 a 3,6)<br /><br />OR 1,5 (0,2 a 11,1)<br /><br />OR 1,1 (0,2 a 5,3)<br /><br />OR 3,2 (1,1 a 9,7)</td> <td align="left"><br /><br />0,897<br /><br />0,082<br /><br />0,179<br /><br />0,545<br /><br />0,658<br /><br />0,717<br /><br />0,933<br /><br />0,033<a href="#tblfn0015">*</a></td> </tr> <tr> <td align="left">SÃ­ntomas; n (%)<br /><br />Fiebre<br /><br />Tos<br /><br />Disnea<br /><br />Mialgia<br /><br />Deterioro del estado funcional<br /><br />ConfusiÃ³n<br /><br />Cefalea<br /><br />Dolor de faringe<br /><br />NÃ¡useas/vÃ³mitos<br /><br />Diarrea<br /><br />Anorexia<br /><br />CaÃ­das<br /><br />DÃ­as entre inicio de sÃ­ntomas e ingreso (DE)</td> <td align="left"><br /><br />18 (52,9)<br /><br />14 (41,2)<br /><br />16 (47,1)<br /><br />2 (5,9)<br /><br />16 (47,1)<br /><br />5 (14,7)<br /><br />1 (2,9)<br /><br />0 (0)<br /><br />1 (2,9)<br /><br />5 (14,7)<br /><br />5 (14,7)<br /><br />2 (5,9)<br /><br /><br /><br />2,67 (4,41)</td> <td align="left"><br /><br />17 (70,8)<br /><br />10 (41,7)<br /><br />15 (62,5)<br /><br />1 (4,2)<br /><br />13 (54,2)<br /><br />6 (25)<br /><br />0 (0)<br /><br />0 (0)<br /><br />3 (12,5)<br /><br />3 (12,5)<br /><br />4 (16,7)<br /><br />1 (4,2)<br /><br /><br /><br />2,5 (2,36)</td> <td align="left"><br /><br />OR 2,2 (0,7 a 6,5)<br /><br />OR 1,02 (0,35 a 2,95)<br /><br />OR 1,9 (0,6 a 5,4)<br /><br />OR 0,7 (0,06 a 8,14)<br /><br />OR 1,3 (0,5 a 3,8)<br /><br />OR 1,9 (0,5 a 7,3)<br /><br />-<br /><br />-<br /><br />OR 4,7 (0,5 a 48,4)<br /><br />OR (0,2 a 3,9)<br /><br />OR 1,2 (0,3 a 4,9)<br /><br />OR 0,7 (0,06 a 8,1)<br /><br /><br /><br />-0,2 (-2,2 a 1,8)</td> <td align="left"><br /><br />0,170<br /><br />0,97<br /><br />0,246<br /><br />0,771<br /><br />0,594<br /><br />0,325<br /><br />0,397<br /><br />-<br /><br />0,297<br /><br />0,81<br /><br />0,839<br /><br />0,771<br /><br /><br /><br />0,867</td> </tr> <tr> <td align="left">RT-PCR; carga viral, copias/1.000 cÃ©lulas (DE)</td> <td align="left">3,91 Ã—10<sup>7</sup> (1,59x10<sup>8</sup>)</td> <td align="left">3,27 Ã—10<sup>7</sup><br /><br />(9,99 Ã—10<sup>7</sup>)</td> <td align="left">-6,34 Ã—10<sup>6</sup><br /><br />(-8 Ã—10<sup>7</sup> a 6,7 Ã—10<sup>7</sup>)</td> <td align="left">0,864</td> </tr> <tr> <td align="left">Leucocitos; Ã—10<sup>9</sup>/L (DE)<br /><br /><i>&amp;lt; 4</i> Ã—<i>10</i><sup><i>9</i></sup><i>/L; n (%)</i><br /><br />Linfocitos; x10<sup>9</sup>/L (DE)<br /><br /><i>&amp;lt; 1</i> Ã—<i>10</i><sup><i>9</i></sup><i>/L; n (%)</i><br /><br />Plaquetas; x10<sup>9</sup>/L (DE)<br /><br /><i>&amp;lt; 100</i> Ã—<i>10</i><sup><i>9</i></sup><i>/L; n (%)</i><br /><br />Hemoglobina; g/L (DE)<br /><br /><i>&amp;lt;12 g/L; n (%)</i></td> <td align="left">6,8 (4,5)<br /><br />7 (20,6)<br /><br />1,1 (0,8)<br /><br />19 (55,9)<br /><br />199,6 (109,4)<br /><br />3 (8,8)<br /><br />12,4 (1,8)<br /><br />15 (44,1)</td> <td align="left">8,7 (3,9)<br /><br />1 (4,2)<br /><br />0,8 (0,5)<br /><br />16 (66,7)<br /><br />193,2 (82,4)<br /><br />1 (4,2)<br /><br />12,8 (1,6)<br /><br />6 (25)</td> <td align="left">1,8 (-0,4 a 4,1)<br /><br /><br /><br />-0,2 (-0,6 a 0,1)<br /><br /><br /><br />-6,5(-59,5 a 46,5)<br /><br /><br /><br />0,4 (-0,5 a 1,3)<br /><br /></td> <td align="left">0,109<br /><br />0,123<br /><br />0,204<br /><br />0,408<br /><br />0,807<br /><br />0,635<br /><br />0,363<br /><br />0,136</td> </tr> <tr> <td align="left">TTPa; segundos (DE)<br /><br />TP; segundos (DE)<br /><br />D-DÃ­mero; microg/L (DE)</td> <td align="left">41,3 (48,3)<br /><br />21,9 (40,7)<br /><br />3965,6<br /><br />(9.890,4)</td> <td align="left">29,9 (5,1)<br /><br />13,8 (1,5)<br /><br />13944,9<br /><br />(32.960,7)</td> <td align="left">-11,4 (-31,3 a 8,4)<br /><br />-8,1 (-24,7 a 8,6)<br /><br />9979,1<br /><br />(-4.284,7 a 24.243,3)</td> <td align="left">0,254<br /><br />0,338<br /><br />0,162</td> </tr> <tr> <td align="left">Glucosa; mg/dL (DE)<br /><br />Sodio; mmol/L (DE)<br /><br />Potasio; mmol/L (DE)<br /><br />Urea; mg/dL (DE)<br /><br />Creatinina; mg/dL (DE)<br /><br />Ferritina; ng/mL (DE)<br /><br />PCR; mg/dL (DE)<br /><br />LDH; U/L (DE)<br /><br />CK; U/L (DE)<br /><br />Troponina T; ng/L (DE)<br /><br />Procalcitonina; ng/mL (DE)<br /><br />AlbÃºmina; g/L (DE)<br /><br />ALT; U/L (DE)<br /><br />AST; U/L (DE)<br /><br />GGT; U/L (DE)<br /><br />Bilirrubina; mg/dL (DE)<br /><br />Fosfatasa alcalina; U/L (DE)<br /><br />NTproBNP; pg/mL (DE)</td> <td align="left">146,2 (85,7)<br /><br />140 (6,4)<br /><br />4,2 (0,8)<br /><br />75,2 (48,2)<br /><br />1,33 (0,78)<br /><br />581,5 (527,3)<br /><br />6,4 (6,2)<br /><br />345,1 (218,2)<br /><br />593,3 (2778,3)<br /><br />64,9 (51,3)<br /><br />0,78 (2,68)<br /><br />33,5 (3,7)<br /><br />22,2 (27,1)<br /><br />73,7 (161,8)<br /><br />62,6 (51,9)<br /><br />1,1 (0,4)<br /><br />96,5 (46,3)<br /><br />4.870,5 (9174)</td> <td align="left">177,5 (99,5)<br /><br />143,4 (8,4)<br /><br />4,2 (0,8)<br /><br />90,1 (52,8)<br /><br />1,55 (0,81)<br /><br />871,7 (859,5)<br /><br />9 (9,9)<br /><br />413,7 (158,4)<br /><br />411,4 (596,8)<br /><br />367,8 (914,5)<br /><br />2 (3,21)<br /><br />33 (3,8)<br /><br />33 (33,8)<br /><br />85,9 (126)<br /><br />57,1 (40,7)<br /><br />1,1 (0,4)<br /><br />104,8 (79,3)<br /><br />5.112,4 (8.803,8)</td> <td align="left">31,3 (-17,6 a 80,3)<br /><br />3,4 (-0,5 a 7,3)<br /><br />0,01 (-0,4 a 0,4)<br /><br />14,8 (-11,9 a 41,6)<br /><br />0,21 (-0,21 a 0,64)<br /><br />290,3 (-147,2 a 727,8)<br /><br />2,6 (-1,6 a 6,9)<br /><br />68,6 (-38,6 a 175,9)<br /><br />-181,8 (-1.420,2 a 1.056,5)<br /><br />302,9 (-102,9 a 708,7)<br /><br />1,2 (-0,5 a 2,9)<br /><br />-0,5 (-2,6 a 1,6)<br /><br />10,7 (-5,7 a 27,1)<br /><br />12,3 (-99,1 a 123,6)<br /><br />-5,5 (-38,6 a 27,5)<br /><br />0,04 (-0,17 a 0,25)<br /><br />8,3 (-25,3 a 41,9)<br /><br />242 (-6.096,9 a 6.580,8)</td> <td align="left">0,205<br /><br />0,088<br /><br />0,955<br /><br />0,271<br /><br />0,321<br /><br />0,188<br /><br />0,219<br /><br />0,205<br /><br />0,769<br /><br />0,136<br /><br />0,152<br /><br />0,642<br /><br />0,195<br /><br />0,823<br /><br />0,736<br /><br />0,725<br /><br />0,622<br /><br />0,939</td> </tr> <tr> <td align="left">RadiologÃ­a; n (%)<br /><br /><i>Sin alteraciones</i><br /><br /><i>NeumonÃ­a unilateral</i><br /><br /><i>NeumonÃ­a bilateral</i><br /><br /><i>Moteado mÃºltiple o patrÃ³n en vidrio deslustrado</i></td> <td align="left"><br /><br />9 (26,5)<br /><br />7 (21,2)<br /><br />12 (36,4)<br /><br /><br /><br />10 (29,4)</td> <td align="left"><br /><br />10 (41,7)<br /><br />0 (0)<br /><br />10 (41,7)<br /><br /><br /><br />10 (41,7)</td> <td align="left"><br /><br />OR 0,5 (0,2 a 1,5)<br /><br />-<br /><br />OR 1,3 (0,4 a 3,7)<br /><br /><br /><br />OR 0,6 (0,2 a 1,7)</td> <td align="left"><br /><br />0,225<br /><br />0,017<a href="#tblfn0015">*</a><br /><br />0,685<br /><br /><br /><br />0,334</td> </tr> <tr> <td align="left">Tratamiento; n (%)<br /><br />Hidroxicloroquina<br /><br />Azitromicina<br /><br />Ceftriaxona<br /><br />Otros antibiÃ³ticos<br /><br />Glucocorticoides</td> <td align="left"><br /><br />5 (14,7)<br /><br />23 (67,6)<br /><br />20 (58,8)<br /><br />10 (29,4)<br /><br />6 (17,6)</td> <td align="left"><br /><br />2 (8,3)<br /><br />19 (79,2)<br /><br />16 (66,7)<br /><br />9 (37,5)<br /><br />4 (16,7)</td> <td align="left"><br /><br />OR 0,5 (0,1 a 3)<br /><br />OR 1,8 (0,5 a 6,2)<br /><br />OR 1,4 (0,5 a 4,2)<br /><br />OR 1,4 (0,5 a 4,4)<br /><br />OR 1,1 (0,3 a 4,3)</td> <td align="left"><br /><br />0,688<br /><br />0,334<br /><br />0,544<br /><br />0,518<br /><br />0,922</td> </tr> <tr> <td align="left">Estancia media; dÃ­as (DE)</td> <td align="left">13,76 (7,22)</td> <td align="left">12,63 (9,56)</td> <td align="left">-1,1 (-5,6 a 3,3)</td> <td align="left">0,607</td> </tr> </tbody> </table> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""> <p>ALT: alanino aminotransferasa; AST: aspartato aminotransferasa; CK: creatina-cinasa; DL: dislipemia; DM: diabetes mellitus; EPOC: enfermedad pulmonar obstructiva crÃ³nica; ERC: enfermedad renal crÃ³nica; GGT: gammaglutamil transferasa; HTA: hipertensiÃ³n arterial; LDH: lactato-deshidrogenasa; PCR: proteÃ­na C reactiva; TP: tiempo de protrombina; TropT: troponina T; TTPa: tiempo de tromboplastina parcial activada.</p> </div> </div> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""><span class="label" tagx="label" title="label">*</span><p id="npar0015">p &amp;lt; 0,05.</p> </div> </div>  <div class="table-wrap_UNKNOWN" position="float" id="tbl0020"><span class="label" tagx="label" title="label">Tabla 4</span> <p>AnÃ¡lisis bivariante entre variables funcionales y cognitivas y mortalidad</p>  <div tag="alt-text">
Tabla 4</div> <table frame="hsides" rules="groups"> <thead> <tr> <th /> <th align="left">No <i>exitus</i><br /><br />(n=34)</th> <th align="left"><i>Exitus</i><br /><br />(n=24)</th> <th align="left">Diferencia de medias vs.<br /><br />OR (ICÂ 95%)</th> <th align="left">p</th> </tr> </thead> <tbody> <tr> <td align="left">IB previo (DE)<br /><br />Dependencia funcional; n (%)<br /><br /><i>independiente (IB 95-100)</i><br /><br /><i>leve (IB 60-90)</i><br /><br /><i>moderada (IB 45-55)</i><br /><br /><i>severa-total (IB 0-40)</i><br /><br />Deterioro cognitivo; n (%)<br /><br /><i>no deterioro cognitivo (GDS 1)</i><br /><br /><i>leve (GDS 2-3)</i><br /><br /><i>moderado-severo (GDS &amp;gt; 3)</i></td> <td align="left">50 (36,7)<br /><br /><br /><br />2 (5,9)<br /><br />13 (38,2)<br /><br />5 (14,7)<br /><br />14 (41,2)<br /><br /><br /><br />11 (32,4)<br /><br />3 (8,8)<br /><br />20 (58,8)</td> <td align="left">26,1 (30,4)<br /><br /><br /><br />0 (0)<br /><br />5 (22,7)<br /><br />1 (4,5)<br /><br />16 (72,7)<br /><br /><br /><br />2 (8,7)<br /><br />3 (13)<br /><br />18 (78,3)</td> <td align="left">â€"23,9 (â€"42,7 a â€"5,02)<br /><br /><br /><br />-<br /><br />OR 0,5 (0,1 a 1,6)<br /><br />OR 0,3 (0,03 a 1,07)<br /><br />OR 3,8 (1,2 a 12,2)<br /><br /><br /><br />-<br /><br />OR 5,5 (0,6 a 49,5)<br /><br />OR 4,9 (1 a 25,4)</td> <td align="left">0,014<a href="#tblfn0020">*</a><br /><br /><br /><br />0,514<br /><br />0,225<br /><br />0,230<br /><br />0,021<a href="#tblfn0020">*</a><br /><br /><br /><br />0,037<a href="#tblfn0020">*</a><br /><br />0,111<br /><br />0,041<a href="#tblfn0020">*</a></td> </tr> </tbody> </table> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""> <p>IB: Ã�ndice de Barthel, GDS: <i>Global Deterioration Scale</i>.</p> </div> </div> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""><span class="label" tagx="label" title="label">*</span><p id="npar0020">p &amp;lt; 0,05.</p> </div> </div> </div> <p /> </div> <div class="discusiÃ³n" title="sec"> <div class="title" tagx="title" title="title">
DiscusiÃ³n</div> <p id="par0135">Los resultados obtenidos ponen de manifiesto la importancia del problema planteado. Nuestra poblaciÃ³n de estudio, pacientes mayores de 80 aÃ±os hospitalizados por COVID-19 con algÃºn grado de dependencia funcional y/o deterioro cognitivo, presenta el doble de tasa de mortalidad que la obtenida en el estudio SEMI-COVID-19 realizado sobre poblaciÃ³n general<a href="#bib0270"><sup>14</sup></a>, siendo aquellos con dependencia funcional grave los que tienen peor pronÃ³stico vital.</p> <p id="par0140">El perfil de los pacientes incluidos en nuestro estudio es el de mujer de 88 aÃ±os de edad, con deterioro cognitivo y dependencia funcional moderada-grave para actividades bÃ¡sicas de la vida diaria. Este perfil de pacientes nos impide saber de forma fehaciente si podemos comparar nuestros resultados con los obtenidos en el resto de series publicadas hasta el momento, debido a que en ellas no se recoge ni describe la situaciÃ³n funcional de los sujetos incluidos<a href="#bib0215">3</a>, <a href="#bib0220">4</a>, <a href="#bib0225">5</a>, <a href="#bib0230">6</a>, <a href="#bib0235">7</a>, <a href="#bib0240">8</a>, <a href="#bib0245">9</a>, <a href="#bib0250">10</a>, <a href="#bib0255">11</a>, <a href="#bib0260">12</a>, <a href="#bib0265">13</a>, <a href="#bib0275">15</a>, <a href="#bib0280">16</a>, <a href="#bib0285">17</a>, <a href="#bib0290">18</a>, <a href="#bib0295">19</a>.</p> <p id="par0145">Hemos detectado una elevada carga de patologÃ­a cardiovascular, HTA, dislipemia y enfermedad renal crÃ³nica que supera las observadas en estudios previos. Mientras que nuestros pacientes presentan enfermedad cardiovascular en el 75,9% de los casos e HTA en el 74,1%, otros autores han descrito prevalencias de enfermedad cardiovascular que varÃ­a del 1,4-40% y de HTA entre el 15 y el 56,6%. Esta diferencia puede estar condicionada por la edad media de nuestra poblaciÃ³n que es notablemente superior a la del resto de estudios, especialmente los realizados con poblaciÃ³n china que suele estar en torno a los 60-70 aÃ±os<a href="#bib0215">3</a>, <a href="#bib0220">4</a>, <a href="#bib0225">5</a>, <a href="#bib0235">7</a>, <a href="#bib0240">8</a>, <a href="#bib0245">9</a>, <a href="#bib0250">10</a>, <a href="#bib0255">11</a>, <a href="#bib0260">12</a>, <a href="#bib0265">13</a>, <a href="#bib0270">14</a>, <a href="#bib0275">15</a>, <a href="#bib0280">16</a>, <a href="#bib0285">17</a>, <a href="#bib0290">18</a>, <a href="#bib0295">19</a>.</p> <p id="par0150">Se ha descrito que la fiebre, la tos y la disnea son los principales sÃ­ntomas de presentaciÃ³n de la infecciÃ³n por SARS-CoV-2, de forma que la fiebre suele referirse en mÃ¡s del 90% de pacientes y la tos en mÃ¡s del 70%<a href="#bib0215">3</a>, <a href="#bib0220">4</a>, <a href="#bib0225">5</a>, <a href="#bib0235">7</a>, <a href="#bib0245">9</a>, <a href="#bib0250">10</a>, <a href="#bib0255">11</a>, <a href="#bib0260">12</a>, <a href="#bib0270">14</a>, <a href="#bib0285">17</a>, <a href="#bib0290">18</a>, <a href="#bib0295">19</a>. Sin embargo, en nuestra muestra pierden fuerza estas manifestaciones tradicionales, la fiebre solo aparece en el 60% de los casos, la disnea en el 53,4% y la tos en el 41,4%. AsÃ­ mismo, adquieren importancia sÃ­ntomas atÃ­picos como el <i>delirium</i>, las caÃ­das o el deterioro del estado funcional. Este Ãºltimo, estando tan presente como en la serie de Bianchetti et al.<a href="#bib0300"><sup>20</sup></a>, supone el tercero en frecuencia, por delante de la tos. Estos resultados confirman la importancia de tener en cuenta, en todo momento y ante cualquier patologÃ­a, la posibilidad de presentaciÃ³n atÃ­pica de la enfermedad en el anciano. Por ello, en funciÃ³n de la situaciÃ³n epidemiolÃ³gica, en pacientes mayores que sufren deterioro del estado funcional, <i>delirium</i> o caÃ­das, deberÃ­amos sospechar la presencia de infecciÃ³n por SARS-CoV-2 independientemente de la existencia de fiebre o tos<a href="#bib0320"><sup>24</sup></a>.</p> <p id="par0155">Respecto a las pruebas analÃ­ticas y radiolÃ³gicas realizadas, nuestros resultados muestran que los pacientes mayores hospitalizados por COVID-19 suelen presentar linfopenia, elevaciÃ³n de d-DÃ­mero, ferritina, PCR, LDH, CK y TropT y un patrÃ³n radiolÃ³gico compatible con neumonÃ­a bilateral o con infiltrados perifÃ©ricos mÃºltiples. Estos resultados son congruentes a los descritos tanto en poblaciÃ³n general como en pacientes mayores de China<a href="#bib0215">3</a>, <a href="#bib0220">4</a>, <a href="#bib0225">5</a><sup>10-12</sup><a href="#bib0285">17</a>, <a href="#bib0290">18</a>.</p> <p id="par0160">Los sujetos incluidos en nuestro estudio reciben en su mayorÃ­a tratamiento con antibioterapia, con especial relevancia de azitromicina y ceftriaxona. En contraste con esta afirmaciÃ³n, se objetiva que son un nÃºmero menor de pacientes los que son tratados con hidroxicloroquina o esteroides, y que ninguno recibe tratamiento con antivirales o inmunoglobulinas, a diferencia de lo descrito en otras series<a href="#bib0260">12</a>, <a href="#bib0280">16</a>, <a href="#bib0285">17</a>.</p> <p id="par0165">Estas diferencias en el manejo terapÃ©utico y la escasa prescripciÃ³n de estos fÃ¡rmacos en nuestra poblaciÃ³n, pueden estar motivadas por varias causas: 1) ninguno ha demostrado ser eficaz en el tratamiento de personas mayores infectadas por SARS-CoV-2 y su prescripciÃ³n se hace de forma empÃ­rica<a href="#bib0325">25</a>, <a href="#bib0330">26</a>; 2) algunos de ellos pueden tener efectos secundarios indeseables muy graves, especialmente en pacientes que presentan un intervalo QT largo<a href="#bib0335"><sup>27</sup></a>; 3) pueden desencadenar interacciones graves con otros fÃ¡rmacos prescritos con relativa frecuencia como antipsicÃ³ticos, antidepresivos y ansiolÃ­ticos<a href="#bib0340"><sup>28</sup></a>; 4) la situaciÃ³n de gravedad clÃ­nica podrÃ­a condicionar escasa o nula tolerancia oral que impidiera la administraciÃ³n de fÃ¡rmacos orales como la hidroxicloroquina; 5) muchos de los pacientes mayores hospitalizados por COVID-19 presentan situaciones de dependencia funcional grave, deterioro cognitivo severo y pluripatologÃ­a con enfermedades crÃ³nicas en fases avanzadas. En todos estos casos la prescripciÃ³n de los fÃ¡rmacos referidos no mejorarÃ­a ni su expectativa de vida ni su calidad de vida. Por ello, en estas personas estarÃ­a indicado prescribir un tratamiento sintomÃ¡tico, aplicar medidas de bienestar y gestionar un acompaÃ±amiento familiar con el objetivo de paliar el sufrimiento en la fase de final de vida<a href="#bib0345"><sup>29</sup></a>.</p> <p id="par0170">Respecto a la mortalidad, hemos detectado una tasa del 41,4%, resultado superior a los registrados en poblaciones chinas mayores de 60 aÃ±os (5,6-19,2%)<a href="#bib0285">17</a>, <a href="#bib0290">18</a> y 65 aÃ±os (34,5%)<a href="#bib0260"><sup>12</sup></a>, inferior a la de Yang et al. en poblaciÃ³n mayor de 70 y 80 aÃ±os (90 y 100%, respectivamente)<a href="#bib0245"><sup>9</sup></a> y algo inferior al obtenido por Richardson et al. en pacientes mayores de 80 aÃ±os ingresados en hospitales de la ciudad de New York (53,7%)<a href="#bib0265"><sup>13</sup></a>. Esta diferencia puede estar condicionada porque nuestra poblaciÃ³n estÃ¡ constituida por pacientes de edad avanzada, un factor de riesgo para desarrollar COVID-19 grave al estar asociada a situaciones de imnunosenescencia y mayor prevalencia de fragilidad y vulnerabilidad, vinculadas a una disminuciÃ³n de la reserva fisiolÃ³gica, de la capacidad intrÃ­nseca y la resiliencia<a href="#bib0350"><sup>30</sup></a>.</p> <p id="par0175">El SARS-CoV-2 es un patÃ³geno respiratorio que penetra en las cÃ©lulas alveolares utilizando los receptores ACE2 (<i>angiotensin converting enzyme 2 receptor</i>) y provoca una serie de cambios patolÃ³gicos que tienen como final comÃºn la disfunciÃ³n alveolar. Este proceso se acompaÃ±a de una tormenta inflamatoria mediada por citocinas, interleucinas e interferÃ³n que, unida a la diseminaciÃ³n viral, extienden el proceso inflamatorio afectando al endotelio de todo el Ã¡rbol vascular y al sistema de coagulaciÃ³n, pudiendo llegar a desencadenar complicaciones cardiovasculares graves y fallo multiorgÃ¡nico<a href="#bib0355">31</a>, <a href="#bib0360">32</a>.</p> <p id="par0180">Estas manifestaciones fisiopatolÃ³gicas se ven potenciadas en las personas mayores, en las que el envejecimiento se acompaÃ±a de disfunciÃ³n endotelial e incremento de los mediadores inflamatorios y los productos resultantes del estrÃ©s oxidativo, provocando un estado de inflamaciÃ³n sistÃ©mica permanente con marcada tendencia a la agregacion, coagulacion y vasoconstriccion<a href="#bib0365"><sup>33</sup></a>. Este estado proagregante y procoagulante en el que viven las personas mayores les confiere mayor vulnerabilidad y gravedad ante la infecciÃ³n por SARS-CoV-2 y tasas mÃ¡s altas de mortalidad.</p> <p id="par0185">A diferencia de otros estudios, no hemos detectado asociaciÃ³n entre sexo, presencia de HTA o enfermedad cardiovascular, sÃ­ntomas como la disnea y niveles de linfocitos, ferritina, troponina-T, d-DÃ­mero, leucocitos o procalcitonina con el riesgo de muerte. Se ha descrito que estos factores podrÃ­an estar reflejando la presencia de <i>distress</i> respiratorio, alteraciones del sistema de coagulaciÃ³n, complicaciones cardiovasculares y sobreinfecciones bacterianas<a href="#bib0360"><sup>32</sup></a>. En nuestro caso, podrÃ­amos establecer como hipÃ³tesis que no llegan a mostrar una asociaciÃ³n significativa debido al pequeÃ±o tamaÃ±o de la poblaciÃ³n de estudio que condiciona menor potencia estadÃ­stica.</p> <p id="par0190">Respecto a la edad, los estudios realizados sobre poblaciÃ³n general hospitalizada por COVID-19 que incluyen sujetos jÃ³venes, adultos y ancianos, describen un incremento progresivo de las tasas de mortalidad a medida que aumenta la edad<a href="#bib0230">6</a>, <a href="#bib0240">8</a>, <a href="#bib0255">11</a>, <a href="#bib0260">12</a>, <a href="#bib0285">17</a>, <a href="#bib0290">18</a>, <a href="#bib0295">19</a>. En nuestra poblaciÃ³n de estudio, al igual que en aquellos dirigidos a sujetos mayores de 80 aÃ±os, no encontramos asociaciÃ³n estadÃ­stica entre edad y riesgo de mortalidad. Esta situaciÃ³n podrÃ­a estar motivada bien por la baja potencia estadÃ­stica, o por ser este grupo etario un conjunto de pacientes muy homogÃ©neo en el que la diferencia de edad entre 80 y 90 o mÃ¡s aÃ±os no condicione diferencias clÃ­nicas ni fisiopatolÃ³gicas que incrementen el riesgo de mortalidad.</p> <p id="par0195">En sentido contrario, la afectaciÃ³n radiolÃ³gica unilateral se asociÃ³ a mayor supervivencia, posiblemente relacionado con que una menor extensiÃ³n de parÃ©nquima pulmonar lesionado conlleve menor gravedad y mortalidad.</p> <p id="par0200">Hemos objetivado que la presencia de ERC se asocia con un aumento del riesgo de desenlace fatal. En pacientes mayores que sufren infecciÃ³n por SARS-CoV-2 la ERC podrÃ­a incrementar la probabilidad de sufrir daÃ±o renal agudo, una de las principales complicaciones de la enfermedad<a href="#bib0245">9</a>, <a href="#bib0255">11</a>, <a href="#bib0265">13</a> y un predictor de mortalidad<a href="#bib0290"><sup>18</sup></a>.</p> <p id="par0205">Los pacientes con dependencia funcional severa y deterioro cognitivo presentaron mÃ¡s riesgo de fallecer durante el ingreso por COVID-19. Estos resultados confirman una vez mÃ¡s las afirmaciones de la OMS que establecen que en las personas mayores la capacidad funcional es el mejor marcador predictivo a escala individual o que la salud en el anciano como mejor se mide es en tÃ©rminos de funciÃ³n<a href="#bib0370">34</a>, <a href="#bib0375">35</a>. La dependencia funcional ha demostrado asociarse a peores resultados de salud en todas las disciplinas mÃ©dicas y quirÃºrgicas, aumentando la incidencia de iatrogenia y eventos adversos, el riesgo de complicaciones y estancias hospitalarias prolongadas y las tasas de institucionalizaciÃ³n, reingresos y mortalidad. La dependencia funcional aumenta el riesgo de muerte a cualquier edad y la dependencia funcional en actividades de la vida diaria es el predictor de mortalidad mÃ¡s potente en personas mayores, haciÃ©ndose mÃ¡s visible cuando la persona mayor es sometida a una situaciÃ³n de mÃ¡ximo estrÃ©s como es la hospitalizaciÃ³n por enfermedad aguda<a href="#bib0380"><sup>36</sup></a>.</p> <p id="par0210">Existen ciertas limitaciones en nuestro trabajo que han de ser consideradas para poder interpretar adecuadamente los resultados. La primera es que es un estudio realizado en una Unidad de Agudos de un Servicio de GeriatrÃ­a y, por ello, no podemos extrapolar los resultados a otros niveles asistenciales (Unidades de Convalecencia, Centros de Larga Estancia, Residencias para Mayores, Hoteles Medicalizados, Hospitales de CampaÃ±a, etcÃ©tera). AsÃ­ mismo, al ser un estudio unicÃ©ntrico, los resultados pueden no ser extrapolables a otros centros. La segunda es que las variables clÃ­nicas, analÃ­ticas y radiolÃ³gicas se recogieron solamente al ingreso por lo que no se puede analizar la asociaciÃ³n entre posibles cambios en estos parÃ¡metros y el riesgo de muerte. La tercera es que al incluir a los pacientes ingresados durante el primer mes de actividad asistencial en las plantas COVID-19, el tamaÃ±o muestral es pequeÃ±o, por lo que aun siendo superior al de otras series disponibles en el momento actual, se ve disminuida la capacidad de inferir las conclusiones a la poblaciÃ³n de pacientes mayores de 80 aÃ±os con algÃºn grado de dependencia funcional. Por Ãºltimo, no se han incluido ninguna de las escalas pronÃ³sticas y de severidad que se estÃ¡n utilizando en nuestro paÃ­s durante la pandemia COVID-19: CURB-65<a href="#bib0385"><sup>37</sup></a>, <i>Pneumonia Severity Index</i> (PSI)<a href="#bib0390"><sup>38</sup></a>, <i>Sepsis-related Organ Failure Assessment</i> (SOFA)<a href="#bib0395"><sup>39</sup></a> o criterios de la <i>American Thoracic Society</i> y la <i>Infectious Diseases Society of America</i> (ATS/IDSA)<a href="#bib0400"><sup>40</sup></a>. Estos instrumentos de valoraciÃ³n del riesgo no estÃ¡n adaptados a poblaciÃ³n anciana, por lo que al ser aplicados sobre mayores de 80 aÃ±os todos los pacientes serÃ­an clasificados como severos/crÃ­ticos restando la posibilidad de discriminar e identificar sujetos con mÃ¡s posibilidades de resultados favorables.</p> <p id="par0215">Como fortalezas, se trata del primer estudio en nuestro paÃ­s que incluye exclusivamente a octogenarios y nonagenarios ingresados por COVID-19 y en el que se tiene en cuenta la situaciÃ³n funcional y el estado cognitivo de los pacientes y su relaciÃ³n con la mortalidad. Con ello, se proporciona un primer acercamiento al estudio de personas mayores de 80 aÃ±os con algÃºn grado de dependencia funcional o deterioro cognitivo hospitalizadas por infecciÃ³n por SARS-CoV-2. Es necesario diseÃ±ar nuevos estudios que profundicen en cuestiones tan relevantes como la presentaciÃ³n atÃ­pica de la enfermedad, las caracterÃ­sticas de los pacientes al ingreso, la efectividad de los tratamientos prescritos o la influencia de la situaciÃ³n basal sobre variables resultado como mortalidad, reingresos o deterioro funcional tras el alta hospitalaria. Todo ello contribuirÃ¡ a ampliar la escasa evidencia cientÃ­fica existente acerca de la COVID-19 en mayores de 80 aÃ±os y nos ayudarÃ¡ a tomar decisiones y a prepararnos para futuros brotes epidÃ©micos.</p> </div> <div class="conclusiones" title="sec"> <div class="title" tagx="title" title="title">
Conclusiones</div> <p id="par0220">Los pacientes mayores de 80 aÃ±os con dependencia funcional o deterioro cognitivo que presentan infecciÃ³n por SARS-CoV-2, sintomatologÃ­a con criterios de hospitalizaciÃ³n y que son ingresados por COVID-19 presentan una elevada tasa de mortalidad.</p> <p id="par0225">Al evaluar la sintomatologÃ­a en pacientes mayores con infecciÃ³n por SARS-CoV-2 a los sÃ­ntomas tÃ­picos como la fiebre, tos y disnea, debemos aÃ±adir sÃ­ntomas atÃ­picos como el <i>delirium</i>, el deterioro del estado funcional y las caÃ­das.</p> <p id="par0230">El grado de dependencia funcional de estos pacientes es un factor pronÃ³stico de forma que las situaciones de dependencia funcional severa presentan mayor riesgo de muerte.</p> <p id="par0235">La valoraciÃ³n funcional en actividades bÃ¡sicas de la vida diaria en el momento del ingreso puede ser Ãºtil para predecir evoluciÃ³n clÃ­nica y establecer estrategias diagnÃ³sticas y de intervenciÃ³n farmacolÃ³gica o implementar programas de cuidados paliativos.</p> </div> <div class="financiaciÃ³n" title="sec"> <div class="title" tagx="title" title="title">
FinanciaciÃ³n</div> <p id="par0240">Este trabajo no ha recibido ningÃºn tipo de financiaciÃ³n.</p> </div> <div class="conflictodeintereses" title="sec"> <div class="title" tagx="title" title="title">
Conflicto de intereses</div> <p id="par0245">Los autores declaran no tener ningÃºn conflicto de intereses.</p> </div> </div> <div class="back" title="back"> <div class="references">
References</div> <div tag="ref-list"> <ul> <div class="title" tagx="title" title="title">
BibliografÃ­a</div> <li tag="ref"><a name="bib0205" /><span class="label" tagx="label" title="label">1</span><span class="element-citation'"><span class="person-group'"><span class="collab'">collab: World Health Organization</span></span><span class="source" tagx="source" title="source">Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV)</span><span class="year" tagx="year" title="year">2020</span><span class="comment">Disponible en: https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov)</span></span></li> <li tag="ref"><a name="bib0210" /><span class="label" tagx="label" title="label">2</span><span class="element-citation'"><span class="person-group'"><span class="collab'">collab: World Health Organization</span></span><span class="source" tagx="source" title="source">WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020</span><span class="year" tagx="year" title="year">2020</span><span class="comment">Disponible en: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020</span></span></li> <li tag="ref"><a name="bib0215" /><span class="label" tagx="label" title="label">3</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">N.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhou</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dong</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Qu</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gong</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Han</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study</span><span class="source" tagx="source" title="source">Lancet.</span><span class="volume" tagx="volume" title="volume">395</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">507</span><span class="lpage" tagx="lpage" title="lpage">513</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32007143">32007143</a></span></span></li> <li tag="ref"><a name="bib0220" /><span class="label" tagx="label" title="label">4</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wu</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yan</span><span class="given-names" tagx="given-names" title="given-names">W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study</span><span class="source" tagx="source" title="source">BMJ.</span><span class="volume" tagx="volume" title="volume">368</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">m1091</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32217556">32217556</a></span></span></li> <li tag="ref"><a name="bib0225" /><span class="label" tagx="label" title="label">5</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Huang</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ren</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhao</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hu</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China</span><span class="source" tagx="source" title="source">Lancet.</span><span class="volume" tagx="volume" title="volume">395</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">497</span><span class="lpage" tagx="lpage" title="lpage">506</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31986264">31986264</a></span></span></li> <li tag="ref"><a name="bib0230" /><span class="label" tagx="label" title="label">6</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ruan</span><span class="given-names" tagx="given-names" title="given-names">Q.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jiang</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Song</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China</span><span class="source" tagx="source" title="source">Intensive Care Med.</span><span class="volume" tagx="volume" title="volume">46</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">846</span><span class="lpage" tagx="lpage" title="lpage">848</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32125452">32125452</a></span></span></li> <li tag="ref"><a name="bib0235" /><span class="label" tagx="label" title="label">7</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hu</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hu</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhu</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China</span><span class="source" tagx="source" title="source">JAMA.</span><span class="volume" tagx="volume" title="volume">323</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">1061</span><span class="lpage" tagx="lpage" title="lpage">1069</span></span></li> <li tag="ref"><a name="bib0240" /><span class="label" tagx="label" title="label">8</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wu</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cai</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xia</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhou</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xu</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China</span><span class="source" tagx="source" title="source">JAMA Intern Med.</span><span class="volume" tagx="volume" title="volume">180</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">1</span><span class="lpage" tagx="lpage" title="lpage">2010011</span></span></li> <li tag="ref"><a name="bib0245" /><span class="label" tagx="label" title="label">9</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yu</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xu</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shu</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xia</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study</span><span class="source" tagx="source" title="source">Lancet Respir Med.</span><span class="volume" tagx="volume" title="volume">8</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">475</span><span class="lpage" tagx="lpage" title="lpage">481</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32105632">32105632</a></span></span></li> <li tag="ref"><a name="bib0250" /><span class="label" tagx="label" title="label">10</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">J.J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dong</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cao</span><span class="given-names" tagx="given-names" title="given-names">Y.Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yuan</span><span class="given-names" tagx="given-names" title="given-names">Y.D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">Y.B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yan</span><span class="given-names" tagx="given-names" title="given-names">Y.Q.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China</span><span class="source" tagx="source" title="source">Allergy.</span><span class="volume" tagx="volume" title="volume">75</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">1730</span><span class="lpage" tagx="lpage" title="lpage">1741</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32077115">32077115</a></span></span></li> <li tag="ref"><a name="bib0255" /><span class="label" tagx="label" title="label">11</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhou</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yu</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Du</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fan</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">Z.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study</span><span class="source" tagx="source" title="source">Lancet.</span><span class="volume" tagx="volume" title="volume">395</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">1054</span><span class="lpage" tagx="lpage" title="lpage">1062</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32171076">32171076</a></span></span></li> <li tag="ref"><a name="bib0260" /><span class="label" tagx="label" title="label">12</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dai</span><span class="given-names" tagx="given-names" title="given-names">Z.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mo</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ma</span><span class="given-names" tagx="given-names" title="given-names">Z.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Song</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Clinical characteristics and outcomes of older patients with coronavirus disease 2019 (COVID-19) in Wuhan, China (2019): a single-centered, retrospective study</span><span class="source" tagx="source" title="source">J Gerontol A Biol Sci Med Sci.</span><span class="year" tagx="year" title="year">2020</span><span class="pub-id"><a href="https://dx.doi.org/10.1093/gerona/glaa089">10.1093/gerona/glaa089</a></span></span></li> <li tag="ref"><a name="bib0265" /><span class="label" tagx="label" title="label">13</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Richardson</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hirsch</span><span class="given-names" tagx="given-names" title="given-names">J.S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Narasimhan</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Crawford</span><span class="given-names" tagx="given-names" title="given-names">J.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">McGinn</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Davidson</span><span class="given-names" tagx="given-names" title="given-names">K.W.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area</span><span class="source" tagx="source" title="source">JAMA.</span><span class="volume" tagx="volume" title="volume">323</span><span class="year" tagx="year" title="year">2020</span><span class="comment">2052-e2067752059</span></span></li> <li tag="ref"><a name="bib0270" /><span class="label" tagx="label" title="label">14</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rojo</span><span class="given-names" tagx="given-names" title="given-names">J.M.C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Santos</span><span class="given-names" tagx="given-names" title="given-names">J.M.A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">NÃºÃ±ez-CortÃ©s</span><span class="given-names" tagx="given-names" title="given-names">J.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bermejo</span><span class="given-names" tagx="given-names" title="given-names">C.L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">RincÃ³n</span><span class="given-names" tagx="given-names" title="given-names">J.M.R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Roy-Vallejo</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Clinical characteristics of patients hospitalized with COVID-19 in Spain: results from the SEMI-COVID-19 Network</span><span class="source" tagx="source" title="source">Medrxiv.</span><span class="year" tagx="year" title="year">2020</span><span class="pub-id"><a href="https://dx.doi.org/10.1101/2020.05.24.20111971">10.1101/2020.05.24.20111971</a></span></span></li> <li tag="ref"><a name="bib0275" /><span class="label" tagx="label" title="label">15</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Godaert</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Proye</span><span class="given-names" tagx="given-names" title="given-names">E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Demoustier-Tampere</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Coulibaly</span><span class="given-names" tagx="given-names" title="given-names">P.S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hequet</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">DramÃ©</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Clinical characteristics of older patients: the experience of a geriatric short-stay unit dedicated to patients with COVID-19 in France</span><span class="source" tagx="source" title="source">J Infect.</span><span class="volume" tagx="volume" title="volume">81</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">e93</span><span class="lpage" tagx="lpage" title="lpage">e94</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.jinf.2020.04.009">10.1016/j.jinf.2020.04.009</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32305489">32305489</a></span></span></li> <li tag="ref"><a name="bib0280" /><span class="label" tagx="label" title="label">16</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lian</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jin</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hao</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cai</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zheng</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Analysis of epidemiological and clinical features in older patients with Corona Virus Disease 2019 (COVID-19) out of Wuhan</span><span class="source" tagx="source" title="source">Clin Infect Dis.</span><span class="year" tagx="year" title="year">2020</span><span class="pub-id"><a href="https://dx.doi.org/10.1093/cid/ciaa242">10.1093/cid/ciaa242</a></span></span></li> <li tag="ref"><a name="bib0285" /><span class="label" tagx="label" title="label">17</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lin</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Han</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Clinical features of COVID-19 in elderly patients: a comparison with young and middle-aged patients</span><span class="source" tagx="source" title="source">J Infect.</span><span class="volume" tagx="volume" title="volume">80</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">e14</span><span class="lpage" tagx="lpage" title="lpage">e18</span></span></li> <li tag="ref"><a name="bib0290" /><span class="label" tagx="label" title="label">18</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">He</span><span class="given-names" tagx="given-names" title="given-names">W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yu</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hu</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bao</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Coronavirus disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up</span><span class="source" tagx="source" title="source">J Infect.</span><span class="volume" tagx="volume" title="volume">80</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">639</span><span class="lpage" tagx="lpage" title="lpage">645</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32240670">32240670</a></span></span></li> <li tag="ref"><a name="bib0295" /><span class="label" tagx="label" title="label">19</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sun</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ning</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tao</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yu</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Deng</span><span class="given-names" tagx="given-names" title="given-names">X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhao</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Risk factors for mortality in 244 older adults with COVID-19 in Wuhan, China: a retrospective study</span><span class="source" tagx="source" title="source">J Am Geriatr Soc.</span><span class="volume" tagx="volume" title="volume">68</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">E19</span><span class="lpage" tagx="lpage" title="lpage">E23</span><span class="pub-id"><a href="https://dx.doi.org/10.1111/jgs.16533">10.1111/jgs.16533</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32383809">32383809</a></span></span></li> <li tag="ref"><a name="bib0300" /><span class="label" tagx="label" title="label">20</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bianchetti</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rozzini</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Guerini</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Boffelli</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ranieri</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Minelli</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Clinical presentation of COVID19 in dementia patients</span><span class="source" tagx="source" title="source">J Nutr Health Aging.</span><span class="volume" tagx="volume" title="volume">24</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">560</span><span class="lpage" tagx="lpage" title="lpage">562</span><span class="pub-id"><a href="https://dx.doi.org/10.1007/s12603-020-1389-1">10.1007/s12603-020-1389-1</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32510106">32510106</a></span></span></li> <li tag="ref"><a name="bib0305" /><span class="label" tagx="label" title="label">21</span><span class="element-citation'"><span class="person-group'"><span class="collab'">collab: Ministerio de Sanidad - Centro de CoordinaciÃ³n de Alertas y Emergencias Sanitarias</span></span><span class="source" tagx="source" title="source">InformaciÃ³n cientÃ­fica-tÃ©cnica. Enfermedad por coronavirus, COVID-19</span><span class="year" tagx="year" title="year">2020</span><span class="comment">Disponible en: https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/20200417_ITCoronavirus.pdf</span></span></li> <li tag="ref"><a name="bib0310" /><span class="label" tagx="label" title="label">22</span><span class="element-citation'"><span class="person-group'"><span class="collab'">collab: Servicio de salud del Principado de Asturias</span></span><span class="source" tagx="source" title="source">Niveles de atenciÃ³n y criterios clÃ­nicos de clasificaciÃ³n de pacientes. Circuito especÃ­fico para centros sociosanitarios. VersiÃ³n 2.0</span><span class="year" tagx="year" title="year">2020</span><span class="comment">Disponible en: https://www.astursalud.es/documents/31867/973133/Niveles+de+Atencion+y+Criterios+Clinicos+de+Clasificacion+del+Pacientes+circuito+especifico+para+centros+sociosanitarios-V-2++31032020.pdf/205a5ce6-8c7e-2830-3009-23c31a1b6b65</span></span></li> <li tag="ref"><a name="bib0315" /><span class="label" tagx="label" title="label">23</span><span class="element-citation'"><span class="person-group'"><span class="collab'">collab: Ministerio de Ciencia e InnovaciÃ³n - Instituto de Salud Carlos III</span></span><span class="source" tagx="source" title="source">Informe del Grupo de AnÃ¡lisis CientÃ­fico del Coronavirus del ISCIII (GACC-ISCIII). Glosario de tÃ©rminos epidemiolÃ³gicos</span><span class="year" tagx="year" title="year">2020</span><span class="comment">Disponible en: https://www.conprueba.es/sites/default/files/noticias/2020-04/GLOSARIO%20DE%20T%C3%89RMINOS%20EPIDEMIOL%C3%93GICOS_1.pdf</span></span></li> <li tag="ref"><a name="bib0320" /><span class="label" tagx="label" title="label">24</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Isaia</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Marinello</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tibaldi</span><span class="given-names" tagx="given-names" title="given-names">V.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tamone</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bo</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Atypical presentation of Covid-19 in an older adult with severe Alzheimer disease</span><span class="source" tagx="source" title="source">Am J Geriatr Psychiatry.</span><span class="volume" tagx="volume" title="volume">28</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">790</span><span class="lpage" tagx="lpage" title="lpage">791</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.jagp.2020.04.018">10.1016/j.jagp.2020.04.018</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32381283">32381283</a></span></span></li> <li tag="ref"><a name="bib0325" /><span class="label" tagx="label" title="label">25</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sanders</span><span class="given-names" tagx="given-names" title="given-names">J.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Monogue</span><span class="given-names" tagx="given-names" title="given-names">M.L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jodlowski</span><span class="given-names" tagx="given-names" title="given-names">T.Z.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cutrell</span><span class="given-names" tagx="given-names" title="given-names">J.B.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review</span><span class="source" tagx="source" title="source">JAMA.</span><span class="volume" tagx="volume" title="volume">323</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">1824</span><span class="lpage" tagx="lpage" title="lpage">1836</span></span></li> <li tag="ref"><a name="bib0330" /><span class="label" tagx="label" title="label">26</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Baden</span><span class="given-names" tagx="given-names" title="given-names">L.R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rubin</span><span class="given-names" tagx="given-names" title="given-names">E.J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Covid-19 - The search for effective therapy</span><span class="source" tagx="source" title="source">N Engl J Med.</span><span class="volume" tagx="volume" title="volume">382</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">1851</span><span class="lpage" tagx="lpage" title="lpage">1852</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32187463">32187463</a></span></span></li> <li tag="ref"><a name="bib0335" /><span class="label" tagx="label" title="label">27</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lane</span><span class="given-names" tagx="given-names" title="given-names">J.C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Weaver</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kostka</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Duarte-Salles</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Abrahao</span><span class="given-names" tagx="given-names" title="given-names">M.T.F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Alghoul</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled case series study</span><span class="source" tagx="source" title="source">Medrxiv.</span><span class="year" tagx="year" title="year">2020</span><span class="pub-id"><a href="https://dx.doi.org/10.1101/2020.04.08.20054551">10.1101/2020.04.08.20054551</a></span></span></li> <li tag="ref"><a name="bib0340" /><span class="label" tagx="label" title="label">28</span><span class="element-citation'"><span class="person-group'"><span class="collab'">collab: Sociedad EspaÃ±ola de GeriatrÃ­a y GerontologÃ­a - SEMEG - SEN - SEPG - Sociedad EspaÃ±ola de PsicogeriatrÃ­a - SEPB - Sociedad EspaÃ±ola de PsiquiatrÃ­a - semFYC - SEMI</span></span><span class="source" tagx="source" title="source">Manejo farmacolÃ³gico de trastornos psicÃ³ticos en personas mayores con tratamiento de la infecciÃ³n por COVID19: interacciones y recomendaciones terapÃ©uticas</span><span class="year" tagx="year" title="year">2020</span><span class="comment">Disponible en: https://www.fesemi.org/sites/default/files/documentos/19.pdf</span></span></li> <li tag="ref"><a name="bib0345" /><span class="label" tagx="label" title="label">29</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Radbruch</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Knaul</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">de Lima</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">de Joncheere</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bhadelia</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">The key role of palliative care in response to the COVID-19 tsunami of suffering</span><span class="source" tagx="source" title="source">Lancet.</span><span class="volume" tagx="volume" title="volume">395</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">1467</span><span class="lpage" tagx="lpage" title="lpage">1469</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32333842">32333842</a></span></span></li> <li tag="ref"><a name="bib0350" /><span class="label" tagx="label" title="label">30</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tarazona-Santabalbina</span><span class="given-names" tagx="given-names" title="given-names">F.J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">MartÃ­nez-Velilla</span><span class="given-names" tagx="given-names" title="given-names">N.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">VidÃ¡n</span><span class="given-names" tagx="given-names" title="given-names">M.T.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">GarcÃ­a-Navarro</span><span class="given-names" tagx="given-names" title="given-names">J.A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">COVID-19, adulto mayor y edadismo: errores que nunca han de volver a ocurrir</span><span class="source" tagx="source" title="source">Rev Esp Geriatr Gerontol.</span><span class="volume" tagx="volume" title="volume">S0211-139X</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">30059-7</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.regg.2020.04.001">10.1016/j.regg.2020.04.001</a></span></span></li> <li tag="ref"><a name="bib0355" /><span class="label" tagx="label" title="label">31</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Varga</span><span class="given-names" tagx="given-names" title="given-names">Z.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Flammer</span><span class="given-names" tagx="given-names" title="given-names">A.J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Steiger</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Haberecker</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Andermatt</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zinkernagel</span><span class="given-names" tagx="given-names" title="given-names">A.S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Endothelial cell infection and endotheliitis in COVID-19</span><span class="source" tagx="source" title="source">Lancet.</span><span class="volume" tagx="volume" title="volume">395</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">1417</span><span class="lpage" tagx="lpage" title="lpage">1418</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32325026">32325026</a></span></span></li> <li tag="ref"><a name="bib0360" /><span class="label" tagx="label" title="label">32</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xu</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dai</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tang</span><span class="given-names" tagx="given-names" title="given-names">N.</span></span></span><span class="mixed-article-title" title="mixed-article-title">SARS-CoV-2 and viral sepsis: observations and hypothesis</span><span class="source" tagx="source" title="source">Lancet.</span><span class="volume" tagx="volume" title="volume">395</span><span class="year" tagx="year" title="year">2020</span><span class="fpage" tagx="fpage" title="fpage">1517</span><span class="lpage" tagx="lpage" title="lpage">1520</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32311318">32311318</a></span></span></li> <li tag="ref"><a name="bib0365" /><span class="label" tagx="label" title="label">33</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Violi</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Loffredo</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Carnevale</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pignatelli</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pastori</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Atherothrombosis and oxidative stress: mechanisms and management in elderly</span><span class="source" tagx="source" title="source">Antioxid Redox Signal.</span><span class="volume" tagx="volume" title="volume">27</span><span class="year" tagx="year" title="year">2017</span><span class="fpage" tagx="fpage" title="fpage">1083</span><span class="lpage" tagx="lpage" title="lpage">1124</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28816059">28816059</a></span></span></li> <li tag="ref"><a name="bib0370" /><span class="label" tagx="label" title="label">34</span><span class="element-citation'"><span class="person-group'"><span class="collab'">collab: World Health Organization</span></span><span class="source" tagx="source" title="source">World report on ageing and health</span><span class="year" tagx="year" title="year">2015</span><span class="comment">Disponible en: https://apps.who.int/iris/bitstream/handle/10665/186463/9789240694811_eng.pdf?sequence=1</span></span></li> <li tag="ref"><a name="bib0375" /><span class="label" tagx="label" title="label">35</span><span class="element-citation'"><span class="person-group'"><span class="collab'">collab: World Health Organization</span></span><span class="mixed-article-title" title="mixed-article-title">The public health aspects of ageing of the population</span><span class="source" tagx="source" title="source">Copenhagen</span><span class="year" tagx="year" title="year">1959</span></span></li> <li tag="ref"><a name="bib0380" /><span class="label" tagx="label" title="label">36</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Socorro GarcÃ­a</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">de la Puente</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Perdomo</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">LÃ³pez Pardo</span><span class="given-names" tagx="given-names" title="given-names">P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">BaztÃ¡n</span><span class="given-names" tagx="given-names" title="given-names">J.J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Functional status and mortality at month and year in nonagenarians hospitalized due to acute medical illness</span><span class="source" tagx="source" title="source">Eur J Intern Med.</span><span class="volume" tagx="volume" title="volume">26</span><span class="year" tagx="year" title="year">2015</span><span class="fpage" tagx="fpage" title="fpage">705</span><span class="lpage" tagx="lpage" title="lpage">708</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26320014">26320014</a></span></span></li> <li tag="ref"><a name="bib0385" /><span class="label" tagx="label" title="label">37</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lim</span><span class="given-names" tagx="given-names" title="given-names">W.S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">van der Eerden</span><span class="given-names" tagx="given-names" title="given-names">M.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Laing</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Boersma</span><span class="given-names" tagx="given-names" title="given-names">W.G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Karalus</span><span class="given-names" tagx="given-names" title="given-names">N.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Town</span><span class="given-names" tagx="given-names" title="given-names">G.I.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study</span><span class="source" tagx="source" title="source">Thorax.</span><span class="volume" tagx="volume" title="volume">58</span><span class="year" tagx="year" title="year">2003</span><span class="fpage" tagx="fpage" title="fpage">377</span><span class="lpage" tagx="lpage" title="lpage">382</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12728155">12728155</a></span></span></li> <li tag="ref"><a name="bib0390" /><span class="label" tagx="label" title="label">38</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Fine</span><span class="given-names" tagx="given-names" title="given-names">M.J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Auble</span><span class="given-names" tagx="given-names" title="given-names">T.E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yealy</span><span class="given-names" tagx="given-names" title="given-names">D.M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hanusa</span><span class="given-names" tagx="given-names" title="given-names">B.H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Weissfeld</span><span class="given-names" tagx="given-names" title="given-names">L.A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Singer</span><span class="given-names" tagx="given-names" title="given-names">D.E.</span></span></span><span class="mixed-article-title" title="mixed-article-title">A prediction rule to identify low-risk patients with community-acquired pneumonia</span><span class="source" tagx="source" title="source">N Engl J Med.</span><span class="volume" tagx="volume" title="volume">336</span><span class="year" tagx="year" title="year">1997</span><span class="fpage" tagx="fpage" title="fpage">243</span><span class="lpage" tagx="lpage" title="lpage">250</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/8995086">8995086</a></span></span></li> <li tag="ref"><a name="bib0395" /><span class="label" tagx="label" title="label">39</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Vincent</span><span class="given-names" tagx="given-names" title="given-names">J.L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Moreno</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Takala</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Willatts</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">De MendonÃ§a</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bruining</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span></span><span class="mixed-article-title" title="mixed-article-title">The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine</span><span class="source" tagx="source" title="source">Intensive Care Med.</span><span class="volume" tagx="volume" title="volume">22</span><span class="year" tagx="year" title="year">1996</span><span class="fpage" tagx="fpage" title="fpage">707</span><span class="lpage" tagx="lpage" title="lpage">710</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/8844239">8844239</a></span></span></li> <li tag="ref"><a name="bib0400" /><span class="label" tagx="label" title="label">40</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Metlay</span><span class="given-names" tagx="given-names" title="given-names">J.P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Waterer</span><span class="given-names" tagx="given-names" title="given-names">G.W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Long</span><span class="given-names" tagx="given-names" title="given-names">A.C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Anzueto</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Brozek</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Crothers</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America</span><span class="source" tagx="source" title="source">Am J Respir Crit Care Med.</span><span class="volume" tagx="volume" title="volume">200</span><span class="year" tagx="year" title="year">2019</span><span class="fpage" tagx="fpage" title="fpage">e45</span><span class="lpage" tagx="lpage" title="lpage">e67</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31573350">31573350</a></span></span></li> </ul> </div> </div>  </body></html>